Carbodiimides for use as a coupling reagent

TBDC salts address the limitations of conventional carbodiimides by offering high solubility, low racemization, and minimal by-products, enabling efficient and environmentally friendly amide bond formation in peptide synthesis.

WO2026234660A1PCT designated stage Publication Date: 2026-11-12Y L EVEN HAROSHE HOLDING LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/IL2026/050297
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-05
Filing Date
2026-03-31
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Conventional carbodiimide coupling reagents suffer from racemization, poor solubility in aqueous and organic solvents, generation of insoluble by-products, and the need for side-chain protecting groups, limiting their effectiveness in peptide and amide bond synthesis.

Method used

The use of 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l-amine salts, particularly the hydrochloride and p-toluenesulfonic acid salt, which exhibit high solubility in both aqueous and organic solvents, stability, and low racemization rates, enabling efficient amide bond formation without the need for side-chain protecting groups.

Benefits of technology

The TBDC salts provide high solubility, low racemization, and minimal by-product formation, facilitating scalable and environmentally friendly amide bond formation in both aqueous and organic media, suitable for large-scale peptide synthesis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000005_0001
    Figure IMGF000005_0001
  • Figure IMGF000010_0001
    Figure IMGF000010_0001
  • Figure IMGF000038_0001
    Figure IMGF000038_0001
Patent Text Reader

Abstract

A composition of matter including a salt made of 3-(((tert-butylimino)methylene)amino)- N,N-dimethylpropan-l -amine and an acid is provided herein and referred toas a coupling reagent. Methods of forming an amide bond effected by using the composition of matter (the coupling reagent) in a liquid medium, including aqueous solutions and water-miscible or green solvents, are also provided. The methods are suitable for peptide synthesis in solution phase and solid phase using amino acid building blocks, including unprotected amino acids such as arginine, histidine, threonine, tryptophan, serine, and tyrosine. Compositions of matter further that include the coupling reagent, a polar or non-polar solvent, and reactants comprising an amine and a carboxylic acid are also disclosed. The coupling reagent provided herein enables high conversion, low racemization, and compatibility with green chemistry principles, offering improved performance in amide bond formation and peptide synthesis.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CARBODIIMIDES FOR USE AS A COUPLING REAGENT

[0002] RELATED APPLICATION / S

[0003] This application claims the benefit of priority of Israel Patent Application No. 320701 filed on May 5, 2025, the contents of which are incorporated herein by reference in their entirety.

[0004] FIELD AND BACKGROUND OF THE INVENTION

[0005] The present invention relates to coupling reagents for promoting amide bond formation in organic synthesis. More specifically, the invention relates to carbodiimide salts for use as a coupling reagent in the formation of amide bonds, including in the synthesis of peptides, particularly in solution-phase processes and in aqueous or partially aqueous media.

[0006] Amide bond formation is a fundamental reaction in organic chemistry, widely used in the synthesis of pharmaceuticals, agrochemicals, polymers, and biologically active molecules, including peptides. Peptide synthesis specifically relies on the efficient formation of amide bonds between amino acids to construct peptide chains. Two principal strategies are employed in peptide synthesis: solid-phase peptide synthesis (SPPS) and liquid- or solution-phase peptide synthesis (LPPS or SolPPS). In SPPS, the growing peptide chain is anchored onto an insoluble solid support, allowing easy removal of excess reagents and by-products. In LPPS, the peptide is assembled entirely in solution, which is particularly suitable for large-scale synthesis and allows for more straightforward scalability, but generally requires careful purification after each coupling step.

[0007] The formation of amide bonds in both solid and solution-phase peptide synthesis typically employs coupling reagents to activate the carboxyl group of an amino acid, facilitating its reaction with the amine group of another amino acid. Carbodiimides have long been employed as effective reagents for the activation of carboxylic acids, enabling their transformation into anhydrides and facilitating peptide bond formation (Chem. Soc. Rev. 2009, 38, 606). This strategy has proven to be invaluable in organic synthesis; however, when a stereogenic center with a labile hydrogen is present at the a-position of the carboxylic acid, racemization can occur during carboxylic acid activation. This issue becomes particularly critical in peptide chemistry, where maintaining stereochemical integrity is essential. Amino acids, which inherently contain such stereogenic centers, are especially prone to racemization during coupling reactions, necessitating the development of alternative activation strategies.

[0008] Among the most widely used coupling reagents are carbodiimides (CDIs), such as N, N’-dicyclohexylcarbodiimide (DCC), N, N’ -diisopropylcarbodiimide (DIC), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC or EDC·HCl). Carbodiimides react with carboxylic acids to form reactive intermediates that promote amide bond formation.

[0009] Despite their widespread use, these conventional carbodiimides suffer from several significant drawbacks. Racemization at the alpha-carbon of amino acids during activation is a persistent problem, particularly when unstable intermediates like O-acylisourea are formed. DCC and DIC are known to promote racemization unless racemization-suppressing additives such as 1-hydroxybenzotriazole (HOBt), 1-hydroxy-7-azabenzotriazole (HOAt), or OxymaPure are used (Aldrichimica Acta 2013, 46, 21; Org. Process Res. Dev. 2018, 22, 760-772). In SPPS, DCC and DIC produce dicyclohexylurea (DCU) and diisopropyl urea (DIU) as by-products, which can precipitate on the resin and affect the next iterative steps or require extensive washings to be removed (DIU). Moving to LPPS, the elimination of DCC, DIC, DCU and DIU cannot take place by simple water washing being all these products insoluble in water.

[0010] EDC·HCl, a water-soluble carbodiimide, is widely used in aqueous-phase peptide synthesis due to its ability to generate water-soluble urea by-products. However, EDC·HCl also suffers from notable drawbacks. It is prone to inducing racemization, particularly in amino acids bearing labile stereocenters such as histidine, cysteine and arginine. Furthermore, EDC·HCl tends to form a cyclic six-membered intermediate structure in solution, as described in Green Chemistry Letters & Reviews 2024, 17, 2392826, leading to reduced reactivity over time. There is the necessity of a CDI and the corresponding urea that are soluble in both organic solvents and water, able to limit the racemization, exhibiting good reactivity and that allowed to avoid the use of sidechain protective groups for Fmoc-histidine and Fmoc-tryptophan to increase overall Atom Economy (AE) of the process.

[0011] Another carbodiimide, tert-butyl-ethylcarbodiimide (TBEC), has been shown to be effective in solid-phase peptide synthesis, notably allowing for the use of unprotected histidine and tryptophan side chains without significant side reactions, as reported in Org. Process Res. Dev.

[0012] 2023, 27, 1348 and in Green Chem. 2024, 26, 10929. However, TBEC is unsuitable for solutionphase peptide synthesis because its by-products, which are highly soluble in organic solvents, cannot be efficiently extracted into water. As a result, residual side-products and unreacted TBEC can contaminate the peptide chain growing in the organic phase, complicating purification and reducing overall synthetic efficiency.

[0013] The current coupling technologies also require the extensive use of side-chain protecting groups to prevent undesired side reactions during peptide synthesis. Protecting groups for amino acid residues such as arginine, histidine, serine, threonine, and tryptophan are typically required,which increases the cost, time, and environmental burden of synthesis. The removal of these protecting groups entails additional synthetic steps and purification operations.

[0014] Thus, although carbodiimide-mediated coupling reactions are central to modem peptide and amide synthesis, the available reagents exhibit substantial limitations. These include racemization, poor performance in aqueous and green solvents, the need for protecting groups, generation of insoluble by-products, and reduced reactivity in certain conditions.

[0015] The compound 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l-amine was previously synthesized and described. In Schmidt et al., " Zur Kenntnis aliphatischer Carbodiimide IV," Berichte der Deutschen Chemischen Gesellschaft, 1948, 81, 222-231, the stability of various carbodiimides was investigated, but there was no disclosure of the synthesis, structure, or properties of 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l-amine. Later, in Schmidt et al., " Zur Kenntnis aliphatischer Carbodiimide X," Liebigs Annalen der Chemie, 1958, 612, 1-22, the synthesis and characterization of (3-dimethylaminopropyl)-(tert-butyl)-carbodiimide were disclosed, corresponding to the free base structure of the aforementioned compound. The 1958 publication describes the preparation, boiling point, solubility, and stability of the compound. However, there is no mention in either the 1948 or 1958 publications of the use of (3-dimethylaminopropyl)-(tert-butyl)-carbodiimide as a coupling reagent in amide bond formation, peptide synthesis, or any other organic transformation. The prior art concerning this compound is limited to its synthesis and basic physical characterization.

[0016] Accordingly, there remains a need in the field for improved carbodiimide-based coupling reagents that are effective in aqueous and organic solvents, that minimize racemization during amide bond formation, that allow the synthesis of peptides without the need for side-chain protecting groups, and that generate by-products that are easily separable from the desired products. There is a further need for coupling reagents that are suitable for large-scale solutionphase synthesis, including applications in green and environmentally friendly solvents.

[0017] SUMMARY OF THE INVENTION

[0018] The present invention provides coupling reagents for amide bond formation, comprising salts of 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l-amine (abbreviated herein to TBDC). The coupling reagents are particularly effective in promoting amide bond formation in organic synthesis, including peptide synthesis. The salts of TBDC, particularly the hydrochloride salt and the p-toluenesulfonic acid salt, exhibit advantageous properties such as high solubility in both aqueous and organic solvents, stability in solution, and the ability to promote amide bond formation with low levels of racemization. The salts are useful in a variety of media, includingenvironmentally friendly solvents and water, thereby enabling peptide synthesis under green chemistry conditions.

[0019] The use of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and its hydrochloride salt (EDC·HCl) as coupling reagents in amide bond formation suffers from significant drawbacks, including poor solubility in organic solvents, high racemization rates, reduced reactivity over time due to intramolecular cyclization, incompatibility with unprotected sensitive amino acids, the need for additional stabilization steps, limited performance in solid-phase peptide synthesis, and the generation of by-products that complicate purification. In contrast, the TBDC salts described herein address these shortcomings by providing high solubility across a wide range of solvents, low racemization, stable open-chain structure, compatibility with unprotected amino acids, inherent stability, effective performance in both aqueous and organic media, and minimal byproduct formation, thereby offering significant advantages for amide bond formation and peptide synthesis.

[0020] The invention further provides methods of forming amide bonds between a carboxylic acid and an amine comprising the step of reacting the carboxylic acid and the amine in the presence of a coupling reagent comprising a salt of TBDC. The methods are suitable for the synthesis of peptides, including the synthesis of peptides from unprotected amino acids in solution-phase peptide synthesis. The coupling reactions promoted by the disclosed carbodiimide salts proceed efficiently with minimal racemization, even in the absence of side-chain protecting groups for amino acids such as arginine, histidine, serine, threonine, tryptophan, and tyrosine. The coupling reagents can be used alone or in combination with additives that further suppress racemization or enhance reaction rates.

[0021] The salts of TBDC overcome several of the limitations associated with conventional carbodiimide coupling reagents. Unlike N, N’ -dicyclohexylcarbodiimide (DCC) and N, N’-diisopropylcarbodiimide (DIC), the salts are highly soluble and do not generate insoluble urea byproducts that complicate purification. Unlike 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl), the disclosed salts do not form cyclic inactive species in solution and exhibit lower racemization rates. Unlike tert-butyl-ethylcarbodiimide (TBEC), the salts are suitable for use in aqueous and organic media and do not cause contamination of the product by insoluble side-products.

[0022] In certain embodiments, the coupling reagents may be used in combination with oxime-based additives, such as OxymaPure, to further minimize racemization and promote the efficient formation of amide bonds. The coupling reagents are particularly suited for the synthesis of peptides in water, in mixtures of water and organic solvents, or in green solvents such as ethylacetate, methyl tetrahydrofuran, and anisole. The salts provide an effective, scalable, and environmentally friendly solution for amide bond formation in chemical synthesis.

[0023] Various embodiments of the present invention relate to methods of forming an amide bond using the coupling reagent provided herein. In some embodiments, the coupling reagent is dissolved in a liquid medium to form a reaction mixture, to which a carboxylic acid and an amine are sequentially added to promote amide bond formation.

[0024] In certain embodiments, the liquid medium is a polar solvent, and in some preferred embodiments, the solvent is a green solvent selected from recognized green solvent selection guides. The reaction may be conducted in aqueous media, in organic solvents, or in mixtures thereof, depending on the solubility of the reactants and desired process parameters.

[0025] In embodiments related to peptide synthesis, the method may be applied to both liquidphase and solid-phase protocols. In liquid- or solution-phase peptide synthesis (LPPS or SolPPS), following coupling, the mixture may directly undergo amino protective group removal before aqueous washing steps are performed. In solid-phase peptide synthesis (SPPS), following coupling and optional washing, the amino protective group is removed, after which the resin is washed, and the cycle is reiterated.

[0026] In further embodiments, the method involves the use of unprotected amino acid building blocks, enabling direct coupling without the need for side-chain protection on residues such as arginine, histidine, threonine, tryptophan, serine, and tyrosine. Where the amino acid building block is in a salified form, a tertiary base, such as triethylamine (TEA) or N, N-diisopropylethylamine (DIPEA), is introduced to free the reactive amine group and facilitate efficient coupling.

[0027] Additional embodiments include reaction mixtures comprising the coupling reagent, a polar solvent, and reactants including an amine and a carboxylic acid, wherein the reaction mixture may further comprise coupling additives to enhance reactivity and suppress racemization.

[0028] The embodiments of the present invention provide flexible, environmentally friendly, and high-efficiency options for amide bond formation and peptide synthesis, supporting high conversion, low racemization, and operational simplicity in both laboratory and industrial settings.

[0029] According to an aspect of some embodiments of the present invention, there is provided a composition of matter including a compound having the formula:

[0030]

[0031] 3-(((?er?-butylimino)methylene)amino)-^’^-dimethylpropan-l-amine(also referred to herein as TBDC or SMILES: CN(C)CCCN=C=NC(C)(C)C) and an acid, wherein a ratio of the compound to the acid ranges from 1.1:0.9 to 0.9: 1.1. This embodiment of the preset invention is also referred to herein as the coupling reagent provided herein, as it comprises or consists of a salt of TBDC, an acid in the specified ratio around 1:1, and an optional solvent.

[0032] In some embodiments, the composition of matter provided herein includes the acid selected from the group comprising p-toluenesulfonic acid (PTSA), methanesulfonic acid (MSA), trifluoromethanesulfonic acid (Triflic acid), benzenesulfonic acid, 2-naphthalenesulfonic acid (NS A), 1,2-ethanedisulfonic acid (DESA), camphorsulfonic acid (CSA), nonafluorobutanesulfonic acid, dioctyl sulfosuccinic acid, chloro sulfonic acid, hydrochloric acid (HC1), hydrobromic acid (HBr), hydroiodic acid (HI), and trifluoroacetic acid (TFA).

[0033] In some embodiments, the composition of matter provided herein is isolated in a solid form; essentially dried and solvent-less.

[0034] In some embodiments, the composition of matter provided herein is isolated in a liquid solution form; essentially the salt dissolved in a substantially pure solvent.

[0035] In some embodiments, the composition of matter provided herein exists substantially in an open-chain form, namely an open-chain carbodiimide rather than a cyclic form.

[0036] In some embodiments, the composition of matter provided herein includes the ratio of the compound to the acid of 1:1, or 1:1 ± 1%.

[0037] According to an aspect of some embodiments of the present invention, there is provided a method of forming an amide bond, which is effected by providing the composition of matter provided herein, dissolving the composition of matter in a liquid medium, and adding a carboxylic acid and an amine to composition of matter to thereby form a reaction mixture, which is an embodiment of the composition of matter.

[0038] In some embodiments, the method provided herein is effected by using the liquid medium that is an aqueous solution and / or a water-miscible solvent.

[0039] In some embodiments, the method provided herein is effected by using the water-miscible solvent selected from the group comprising acetone, dimethyl sulfoxide (DMSO), ethanol (EtOH), methanol (MeOH), isopropanol (2-propanol or iPrOH), propylene glycol (1,2-propanediol), ethylene glycol (1,2-ethanediol), glycerol (1,2,3-Propanetriol), acetonitrile (ACN), 1,4-dioxane, tetrahydrofuran (THF), N, N-dimethylformamide (DMF), N-methyl-2-pyrrolidone (NMP), pyridine, triethylamine (TEA), N, N-diisopropylethylamine (DIPEA), formamide, dimethylacetamide (DMAc), t-butyl alcohol (tBuOH), acetaldehyde, 2-methoxyethanol, 2-ethoxyethanol, 1,3 -propanediol (1,3 -Dihydroxypropane), 1,2-butanediol (1,2-Dihydroxybutane), 1,3 -butanediol (1,3-dihydroxybutane), 1,4-butanediol and any mixture thereof.

[0040] In some embodiments, the method provided herein is effected by using the water-miscible solvent selected from the group comprising ethanol, methanol, isopropanol, propylene glycol, ethylene glycol, glycerol, acetone, acetonitrile and any mixture thereof.

[0041] In some embodiments, the method provided herein is effected iteratively in a peptide synthesis process using at least two amino acid building blocks, wherein at least one of the amino acid building blocks is the carboxylic acid.

[0042] In some embodiments, the method provided herein is effected by conducting the peptide synthesis in solid phase.

[0043] In some embodiments, the method provided herein is effected by using the medium that is a solvent substantially immiscible in water.

[0044] In some embodiments, the method provided herein is effected by using the solvent that is a green solvent, as defined in a recognized solvent selection guide selected from the group consisting of the CHEM21 guide, the Pfizer guide, and the GSK guide.

[0045] In some embodiments, the method provided herein is effected by using the solvent selected from the group including ethyl acetate (EtOAc), methyl ethyl ketone (MEK), isopropyl acetate (iPrOAc), cyclopentyl methyl ether (CPME), 2-methyltetrahydrofuran (2-MeTHF), dimethyl carbonate (DMC), propylene carbonate (PC), y-valerolactone (GVL), dimethyl isosorbide (DMI), ethylene carbonate (EC), and any combination thereof.

[0046] In some embodiments, the method provided herein is effected iteratively in a peptide synthesis process using at least two amino acid building blocks, wherein at least one of the amino acid building blocks is the carboxylic acid.

[0047] In some embodiments, the method provided herein is effected by conducting the peptide synthesis in solution phase.

[0048] In some embodiments, the method provided herein further includes, subsequent to adding the carboxylic acid and the amine, washing the reaction mixture with an aqueous solution.

[0049] In some embodiments, the method provided herein is effected by using at least one amino acid building block selected from the group comprising a histidine building block, an arginine building block, a threonine building block, a tryptophan building block, a serine building block, and a tyrosine building block, and wherein a side-chain thereof is not protected.

[0050] In some embodiments, the method provided herein is effected by conducting the peptide synthesis in solid phase.In some embodiments, the method provided herein is effected by using at least one amino acid building block selected from the group comprising a histidine building block, an arginine building block, a threonine building block, a tryptophan building block, a serine building block, and a tyrosine building block, and wherein a side-chain thereof is not protected.

[0051] In some embodiments, the method provided herein is effected by forming the amide bond with a conversion of at least 95% and with an L: D enantiomeric ratio greater than 95:5.

[0052] According to an aspect of some embodiments of the present invention, there is provided a composition of matter that includes TBDC (the compound having the SMILES: CN(C)CCCN=C=NC(C)(C)C)) and an acid at a ratio range of from 1.1:0.9 to 0.9: 1.1, and further includes a polar or non-polar solvent, at least one reactant that includes at least one amine and / or at least one carboxylic acid, and / or at least one product that includes at least one amide or at least one peptide. This embodiment of the composition of matter is also referred to as a reaction mixture.

[0053] In some embodiments, the composition of matter provided herein includes a solvent selected from the group consisting of water, ethyl acetate, methyl ethyl ketone, isopropyl acetate, cyclopentyl methyl ether, 2-methyltetrahydrofuran, dimethyl carbonate, propylene carbonate, y-valerolactone, dimethyl isosorbide, ethylene carbonate, tetrahydrofuran (THF), anisole, and mixtures thereof.

[0054] In some embodiments, the composition of matter provided herein includes the solvent that comprises water or a mixture of water with a water-miscible solvent selected from acetone, dimethyl sulfoxide (DMSO), ethanol, methanol, isopropanol, propylene glycol, ethylene glycol, glycerol, acetonitrile, 1,4-dioxane, tetrahydrofuran (THF), N, N-dimethylformamide (DMF), N-methyl-2-pyrrolidone (NMP), pyridine, triethylamine (TEA), N, N-diisopropylethylamine (DIPEA), formamide, dimethylacetamide (DMAc), t-butyl alcohol, acetaldehyde, 2-methoxyethanol, 2-ethoxyethanol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, and 1,4-butanediol.

[0055] In some embodiments, the composition of matter provided herein, or the reaction mixture, includes the amine and the carboxylic acid that are amino acid building blocks.

[0056] In some embodiments, the composition of matter provided herein, or the reaction mixture, includes at least one amino acid building block that is unprotected on its side chain.

[0057] In some embodiments, the composition of matter provided herein, or the reaction mixture, includes the unprotected amino acid building block selected from the group consisting of arginine, histidine, threonine, tryptophan, serine, and tyrosine.In some embodiments, the composition of matter provided herein, or the reaction mixture, includes the coupling reagent provided herein, present in an amount of 1.1 to 7.5 equivalents relative to the total amount of at least one reactant.

[0058] In some embodiments, the composition of matter provided herein, or the reaction mixture, further includes a tertiary base selected from the group consisting of triethylamine (TEA) and N, N-diisopropylethylamine (DIPEA).

[0059] In some embodiments, the composition of matter provided herein, or the reaction mixture, further includes a coupling additive.

[0060] In some embodiments, the composition of matter provided herein, or the reaction mixture, is in the form of a single homogeneous phase.

[0061] DESCRIPTION OF EMBODIMENTS OF THE INVENTION

[0062] The present invention relates to coupling reagents for promoting amide bond formation in organic synthesis. More specifically, the invention relates to carbodiimide salts for use as a coupling reagent in the formation of amide bonds, including in the synthesis of peptides, particularly in solution- and liquid-phase processes and in aqueous or partially aqueous media.

[0063] Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details set forth in the following description or exemplified by the Examples. The disclosure is meant to encompass other embodiments or of being practiced or carried out in various ways.

[0064] While conceiving the present invention, the present inventors envisioned a coupling reagent that would enable efficient amide bond formation with low racemization, high solubility in polar and green solvents, compatibility with non-protected side-chain amino acid building blocks, and stability under reaction conditions suitable for both solid-phase and solution- and liquid-phase peptide synthesis.

[0065] While reducing the present invention to practice, the present inventors have demonstrated that salts of 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l-amine combined with selected acids serve as highly effective coupling reagents, achieving high conversion rates, minimal racemization, excellent solubility in aqueous and organic media, and compatibility with environmentally friendly solvents and unprotected amino acids in peptide synthesis.

[0066] A coupling reagent:

[0067] Thus, according to some embodiments of the present invention, there is provided a coupling reagent in the form of a composition of matter, which includes a compound, which is a carbodiimide having the formula:

[0068]

[0069] 3-(((?er?-butylimino)methylene)amino)-^’^-dimethylpropan-l-amine

[0070] and an acid, wherein the ratio of the compound to the acid ranges 1.1:0.9 - 0.9- 1.1. In some embodiments the compound to acid ratio ranges 1.05:0.95 - 0.95:1.05, and in some embodiments the ratio is 1:1 as determined by standard analytical methods, including, but not limited to NMR spectroscopy.

[0071] In the context of the present inventio, the compound is a carbodiimide (CDI), which is also referred to herein as TBDC. Herein and throughout, a reference to a coupling reagent is equivalent to a reference to the composition of matter comprising at least TBDC and an acid in a specified ratio, typically on a range of 1.1:0.9 to 0.9: 1.1, or 1:1.

[0072] The combination of an organic base, such as TBDC, and an acid, is typically a salt, particularly in a polar medium environment, such as water. In some embodiments of the present invention, the acid is represented by the non-limiting examples including p-toluenesulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, 2-naphthalenesulfonic acid, 1,2-ethanedisulfonic acid, camphorsulfonic acid, nonafluorobutane sulfonic acid, dioctyl sulfosuccinic acid, chloro sulfonic acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, and trifluoroacetic acid, and any combination thereof.

[0073] The ratio refers to the molar equivalent of the acid and the CDI, rather than the exact type of acid. Hence, the coupling reagent can be represented by an ammonium cation based on a protonated form of TBDC and an anion stemming from the acid, as listed below.

[0074] Tosylate (TsO ), derived from: p-Toluenesulfonic acid, typically used as a leaving group in organic synthesis; forms stable salts with amines and other bases.

[0075] Mesylate (MsO ), derived from: Methanesulfonic acid, typically used a leaving group and counterion in pharmaceuticals and organic reactions.

[0076] Triflate (CF3SO3 ), derived from: Trifluoromethanesulfonic acid, typically used a leaving group due to strong electron- withdrawing trifluoromethyl group; common in catalysis and organic synthesis.

[0077] Besylate (C₆H₅SO₃⁻), derived from: Benzenesulfonic acid, typically used as a counterion in pharmaceuticals (e.g., amlodipine besylate) for solubility and stability.Napsylate (C₁₀H₇SO₃⁻), derived from: 2-Naphthalenesulfonic acid, typically used to forms stable salts with basic drugs (e.g., dextromethorphan napsylate).

[0078] Edisylate (HO₃S(CH₂)₂SO₃⁻), derived from: 1,2-Ethanedisulfonic acid, typically used as a dianion and as a counterion to improve drug crystallinity and solubility.

[0079] Camphorsulfonate (C₁₀H₁₅SO₄⁻), derived from: Camphorsulfonic acid, typically used as a chiral resolving agent in asymmetric synthesis and pharmaceuticals.

[0080] Nonaflate (C₄F₉SO₃⁻), derived from: Nonafluorobutanesulfonic acid, typically used as a highly electron-deficient leaving group for challenging reactions.

[0081] Docusate (C₂₀H₃₇O₇S⁻), derived from: Dioctyl sulfosuccinic acid, typically used as a surfactant counterion in laxatives (e.g., docusate sodium).

[0082] Closilate (ClSO₃⁻), derived from: Chlorosulfonic acid, typically used in niche sulfonation reactions.

[0083] Chloride (Cl⁻), Bromide (Br⁻) / Iodide (I⁻), typically used as a small inorganic leaving groups, though less stable than sulfonates.

[0084] Trifluoroacetate (CF₃COO⁻), derived from: Trifluoroacetic acid, typically used to stabilizes intermediates in peptide synthesis and as a volatile counterion.

[0085] The coupling reagent provided herein can be in an isolate form, namely as a single chemical entity consisting of the CDI and the acid in the designated ratio, with or without a carrier, a medium or a solvent. The coupling reagent, or the corresponding equivalent salt, can be in a solid form or as a solute in a solution (liquid medium).

[0086] The coupling reagent provided herein is present in an open-chain conformation, namely the CDI does not exhibit a tendency to form cyclized isomers or conformers.

[0087] Method and Processes using the Coupling Reagent:

[0088] According to some embodiments of the present invention, there is provided a method of forming an amide bond between an amine group and a carboxyl group, utilizing the composition of matter described above, namely the coupling reagent provided herein, wherein the ratio of the carbodiimide compound to the acid is from about 1.1:0.9 to about 0.9: 1.1. The method comprises dissolving or dispersing the coupling reagent in a liquid medium to form a reaction mixture, introducing a carboxylic acid into the reaction mixture, and subsequently introducing an amine into the reaction mixture, which is intended to be coupled to the carboxylic acid. A reaction mixture is an embodiment of the composition of matter described above, with mixed or suspended in a liquid medium comprising an optional and / or optimal solvent, and reactants, such as the building blocks to be coupled together via an amide bond. In some embodiments, this compositionof matter referred to as a reaction mixture, comprises the coupling reagent provided herein dissolved or suspended in a liquid medium comprising an optional solvent other than the solvent than the coupling reagent is initially dissolved in, at least one reactant which can be a carboxylic acid or an amine, and in some embodiments, the reaction mixture may also include a product, such as an amide or a peptide, afforded by the coupling reaction between the reactants. In some embodiments, the reaction mixture may also include other additives, such as OxymaPure, 1-hydroxybenzotriazole (HOBt), 1-hydroxy-7-azabenzotriazole (HOAt), l-hydroxy-6-oxo-lH-benzotriazole (HOOBt), or l-hydroxy-7-oxo-lH-pyrrolo[2,3-b]pyridine (HOPO), dissolved in a corresponding solvent.

[0089] The liquid medium may be any suitable medium that allows the coupling reagent to function effectively, including aqueous solutions, water-miscible organic solvents, water-immiscible solvents, or mixtures thereof. In some embodiments, the solvent is a polar solvent, and in certain embodiments, the solvent is a green solvent, selected from recognized solvent selection guides such as the CHEM21 guide, the Pfizer guide, and the GSK guide. Exemplary solvents include water, ethyl acetate, methyl ethyl ketone, isopropyl acetate, cyclopentyl methyl ether, 2-methyltetrahydrofuran, dimethyl carbonate, propylene carbonate, y-valerolactone, dimethyl isosorbide, ethylene carbonate, and mixtures thereof.

[0090] In embodiments where the liquid medium is substantially immiscible with water, an additional washing step may be performed following the coupling reaction to remove residual reagents, reactants, and by-products such as the urea derivative resulting from the carbodiimide coupling reaction. Washing may be accomplished by adding an aqueous solution to the reaction mixture, followed by phase separation.

[0091] In embodiments directed to peptide synthesis, including both liquid- or solution-phase peptide synthesis (LPPS or SolPPS) and solid-phase peptide synthesis (SPPS), the method further includes iterative cycles of coupling, deprotection, and washing. In a liquid- or solution-phase peptide synthesis protocol, the reaction mixture, following complete coupling, may undergo direct amino protecting group removal prior to aqueous washing. This enables efficient removal of residual coupling reagent, by-products, and protecting group fragments without premature dilution or loss of the peptide product.

[0092] In a solid-phase peptide synthesis protocol, the coupling reaction is conducted on a solid support resin. Following coupling, the resin is washed with the selected solvent to remove unreacted materials and by-products. Subsequently, the amino protecting group, such as an Fmoc group, is removed by treatment with a suitable deprotection agent, including secondary amines such as piperidine (Pip), 4-methylpiperidine (4-MePip), piperazine, morpholine, or diethylamine(DEA), in a corresponding solvent. Alternatively, deprotection may be performed using DBU in combination with a secondary amine. The deprotected resin is then washed, and the next coupling cycle is initiated. In alternative SPPS embodiments, the amino protective group may be removed immediately after coupling, followed by washing, allowing flexibility in synthesis planning based on resin characteristics and peptide sequence.

[0093] In some embodiments, the method includes forming a reaction mixture by combining the coupling reagent provided herein, a polar solvent or mixture thereof, and reactants comprising a carboxylic acid and an amine. In preferred embodiments, the reactants are amino acid building blocks, and the method is conducted to form a peptide bond. More particularly, the amino acid building blocks may be unprotected on their side chains, allowing the synthesis of peptides without the need for protecting groups on amino acid residues such as arginine, histidine, threonine, tryptophan, serine, and tyrosine.

[0094] In certain embodiments, the coupling step is conducted in the presence of a coupling additive such as OxymaPure, HOBt, HOAt, HOOBt, or HOPO, to further suppress racemization and improve coupling efficiency. In embodiments where the amino acid building block is provided as a salt, for example, a hydrochloride salt, the method further includes adding a tertiary base, such as triethylamine (TEA) or N, N-diisopropylethylamine (DIPEA), to the reaction mixture. The tertiary base deprotonates the protonated amino group, thereby restoring its nucleophilicity and enabling efficient amide bond formation.

[0095] In specific embodiments directed to SPPS, the coupling reagent provided herein, namely salts of TBDC (4.5–7.5 equivalents), are mixed with the Fmoc-protected amino acid (3–5 equivalents) and the coupling additive (3–5 equivalents) dissolved in the appropriate solvent, optionally in the presence of a tertiary base (4.5–7.5 equivalents). The mixture is allowed to preactivate for about 1–10 minutes, followed by addition to the amino-functionalized resin (e.g., RinkAmide, Ramage, Sieber, H-AA-O-Wang, or H-AAZ-O-CTC resin). The coupling reaction is allowed to proceed for 30 minutes to 2 hours. After coupling, the solution is filtered, and the resin is washed thoroughly with solvent. The Fmoc group is removed using a solution of a secondary amine (10–60% concentration) or with a combination of DBU and secondary amine (2–5% concentrations each) for 5–30 minutes. The unprotected resin is then washed, and the cycle is repeated until the full sequence of the target peptide is assembled.

[0096] In specific embodiments directed to solution-phase peptide synthesis, after coupling, the reaction mixture may optionally undergo immediate amino protective group removal before aqueous washing, enabling streamlined synthesis.In accordance with some embodiments of the present invention, the coupling reagent comprising a salt of 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l-amine (TBDC) may be employed for the formation of amide bonds in non-polar solvents under conditions suitable for solid- supported peptide synthesis. In a representative embodiment, TBDC salt in an amount of approximately 1.6 to 2.0 equivalents relative to the resin loading is dissolved together with a protected amino acid, such as Fmoc-AAY-OH, in a non-polar solvent. Suitable non-polar solvents include tetrahydrofuran (THF) and anisole. The reaction mixture further comprises a coupling additive, such as OxymaPure, 1 -hydroxybenzotriazole (HOBt), 1-hydroxy-7-azabenzotriazole (HOAt), l-hydroxy-6-oxo-lH-benzotriazole (HOOBt), or l-hydroxy-7-oxo-lH-pyrrolo[2,3-b]pyridine (HOPO), in an amount of approximately 1.6 to 2.0 equivalents.

[0097] The reaction mixture may optionally include a tertiary base such as N, N-diisopropylethylamine (DIEA) or triethylamine (TEA) in cases where the amino acid building block is salified, that is, exists in a protonated form paired with a counter-ion such as chloride. The tertiary base deprotonates the salified amino acid, thus restoring the nucleophilicity of the amine group necessary for effective amide bond formation. The reaction mixture is allowed to preactivate for a period ranging from about 1 to about 10 minutes prior to introduction onto a solid-supported linker system.

[0098] Following pre-activation, the reaction mixture is added to a polymer- supported amino linker bearing a tagging group (TAG), such as RinkAmide-TAG, Ramage-TAG, Sieber-TAG, AA-Wang-TAG, or AA-CTC-TAG. Coupling proceeds under ambient conditions for approximately 30 to 60 minutes or until a ninhydrin test indicates completion of the coupling reaction. After completion of the coupling, deprotection of the Fmoc protecting group is achieved by addition of a secondary amine such as piperidine in an amount of 10 to 25 equivalents, with the deprotection step allowed to proceed for 10 to 30 minutes.

[0099] Upon completion of deprotection, the reaction mixture is concentrated, and the product is precipitated or isolated by centrifugation through the addition of 6 to 10 volumes of a cold polar solvent such as methanol, isopropanol, or acetonitrile. The isolated solid is washed at least twice with additional cold polar solvent to remove residual reagents and side products. This cycle of coupling, deprotection, and washing is repeated iteratively until the full sequence of the desired peptide has been synthesized.

[0100] In an alternative embodiment, when anisole is employed as the reaction solvent, deprotection following the coupling step may be performed using piperazine instead of piperidine. After deprotection, the anisole reaction mixture is washed successively with aqueous hydrochloric acid solution, aqueous sodium carbonate solution, and saturated brine, followed by drying overanhydrous magnesium sulfate. This alternative protocol provides additional flexibility in solvent selection and workup for peptide synthesis on solid supports utilizing TBDC salts.

[0101] In all embodiments, the method provides high coupling efficiency, minimal racemization, compatibility with green and aqueous solvents, and flexibility between solid and liquid- or solution-phase protocols. Reaction conversions of at least 95% and L: D ratios greater than 95:5 are achieved under optimized conditions. The use of TBDC salts as coupling reagents in the described methods significantly improves synthetic efficiency, environmental friendliness, and process scalability over conventional carbodiimide-based coupling systems.

[0102] In the context of peptide synthesis, amino acid building blocks may sometimes be provided in salified form. A salified amino acid building block refers to an amino acid in which the main amine group and / or a side-chain functional group have been protonated and paired with a counterion, such as a chloride ion, forming for example an amino acid hydrochloride salt. The salification of the amine group renders the amino acid cationic and substantially reduces its nucleophilicity. As a result, the protonated amine group is unable to efficiently react with an activated carboxylic acid group to form an amide bond under standard coupling conditions.

[0103] To enable effective coupling in the presence of salified amino acids, a tertiary base is introduced into the reaction medium. The tertiary base serves to neutralize the protonated amine by abstracting the proton, thereby regenerating the free amine group (NH₂) capable of nucleophilic attack on the activated carboxyl group. Suitable tertiary bases include, but are not limited to, triethylamine (TEA) and N, N-diisopropylethylamine (DIPEA). The use of a tertiary base is particularly important when the coupling reagent is introduced in the form of a pre-formed salt, as described herein, because the activation process itself does not deprotonate the amino acid substrate.

[0104] In the methods of the present invention, even when the coupling reagent provided herein comprises a salt of 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l-amine (TBDC), it remains necessary to provide a tertiary base in the reaction mixture when salified amino acid building blocks are employed. The addition of the tertiary base ensures that the amino acid's nucleophilic amine is available for coupling, thereby facilitating efficient formation of the desired amide or peptide bond. This approach enables the direct use of commercially available amino acid salts without the need for pre-treatment, thus simplifying synthetic procedures and broadening the scope of compatible starting materials.

[0105] In some embodiments, the tertiary base is added in an amount sufficient to fully deprotonate the salified amine groups without causing undesired side reactions or degradation ofsensitive functional groups present on the amino acid building blocks or in the growing peptide chain.

[0106] A Reaction Mixture Comprising the Coupling Reagent:

[0107] The present invention further provides a composition of matter, also referred to herein as a reaction mixture, as presented hereinabove, which includes the coupling reagent provided herein, a solvent, and reactants suitable for effecting an amide bond formation, and in some embodiments also the product of the coupling reaction, namely an amide and / or a peptide. The reaction mixture aspect represents a tangible composition of matter that combines at least the necessary elements for amide bond formation including the coupling reagent provided herein.

[0108] The reaction mixture further comprises a solvent capable of maintaining the coupling reagent, the carboxylic acid, and optionally the amine to be coupled therewith, in a homogeneous phase or a reactive dispersion. Suitable solvents include polar and non-polar solvents, aqueous solutions, or mixtures thereof. Non-limiting examples include water, ethyl acetate, methyl ethyl ketone, isopropyl acetate, cyclopentyl methyl ether, 2-methyltetrahydrofuran, dimethyl carbonate, propylene carbonate, y-valerolactone, dimethyl isosorbide, ethylene carbonate, tetrahydrofuran, anisole, and mixtures of any of the foregoing.

[0109] In certain embodiments, the reaction mixture further comprises an amine and a carboxylic acid capable of undergoing amide bond formation under the reaction conditions. In preferred embodiments, the reactants are amino acid building blocks, including optionally non-protected amino acid derivatives. The use of unprotected amino acids is particularly advantageous, as it simplifies synthetic protocols by eliminating the need for side-chain protection strategies. Amino acid building blocks such as arginine, histidine, threonine, tryptophan, serine, and tyrosine may be employed without side-chain protecting groups.

[0110] In certain embodiments, the reaction mixture further comprises a tertiary base, such as triethylamine (TEA) or diisopropylethylamine (DIPEA), when salified amino acid reactants are present. The tertiary base serves to deprotonate protonated amino groups, restoring their nucleophilicity and facilitating efficient amide bond formation.

[0111] In additional embodiments, the reaction mixture includes a coupling additive such as OxymaPure, 1 -hydroxybenzotriazole (HOBt), 1-hydroxy-7-azabenzotriazole (HOAt), 1-hydroxy-6-oxo- IH-benzo triazole (HOOBt), or l-hydroxy-7-oxo-lH-pyrrolo[2,3-b]pyridine (HOPO), to enhance reaction rates and suppress racemization.

[0112] Typically, the coupling reagent is present in the reaction mixture in an amount of 1.1 to 7.5 equivalents relative to the limiting reactant, the tertiary base when present is used in similar orslightly lower amounts, and the coupling additive is used at equimolar to slight excess relative to the coupling reagent.

[0113] In some embodiments, the reaction mixture is prepared to exist as a single homogeneous phase at ambient temperature, although in certain applications, heterogeneous mixtures may also be employed when advantageous.

[0114] The ability to define and identify the complete reaction mixture provides a tangible product distinct from the coupling reagent or the method of use. This tangible formulation can be detected and characterized by the presence of the coupling reagent in the specified form, the solvent medium, the amine and carboxylic acid reactants, and, optionally, the tertiary base and coupling additive.

[0115] Comparison to other CDIs:

[0116] EDC·HCl presents several drawbacks in peptide synthesis. It has poor solubility in common organic solvents like DMF, DCM, and ethyl acetate, restricting its use primarily to aqueous-phase synthesis. It tends to promote racemization during coupling reactions and exists as a mixture of cyclic and linear forms, potentially affecting reaction efficiency. Additionally, it shows undesired reactivity with histidine side chains. These limitations constrain EDC·HCl's effectiveness across various synthetic protocols, particularly those requiring flexibility in solvent selection. In contrast, the TBDC salts described herein offer significant advantages. They have excellent solubility in both aqueous and organic solvents, enabling efficient peptide bond formation in a broader range of reaction environments. They also show a reduced tendency for racemization, preserving stereochemical integrity. TBDC salts do not form cyclic forms, potentially improving reaction predictability and yield, and they exhibit diminished reactivity with histidine side chains, allowing for more selective coupling. The presence of the tert-butyl group in TBDC salts is key to these improvements, particularly in enhancing organic solvent solubility and preventing the undesired side reaction with the His side chain. These characteristics collectively expand the utility of TBDC salts in diverse peptide synthesis applications, overcoming many of the limitations associated with EDC·HCl.

[0117] EDC in its free base form, and EDC·HCl as its hydrochloride salt, both exhibit a high tendency to induce racemization when activating carboxylic acids for amide bond formation. This propensity to promote stereochemical erosion is particularly problematic in the synthesis of peptides containing sensitive chiral centers, resulting in undesirable formation of D-isomers alongside the intended L-amino acid sequences. By comparison, the TBDC salts demonstrate significantly lower racemization rates, maintaining the optical purity of the resulting peptides even when unprotected or stereochemically labile amino acids are employed.EDC in solution readily forms a six-membered cyclic structure through internal reaction of its carbodiimide group with its tertiary amine functionality. This intramolecular cyclization reduces the amount of active coupling reagent available in solution, thereby diminishing coupling efficiency over time. The phenomenon necessitates either rapid reaction times or use of excess reagent, leading to inefficiencies. In contrast, the TBDC salts described in the present invention exist exclusively in an open, linear form, as confirmed by NMR analysis, thereby ensuring stable and sustained reactivity throughout the course of the coupling reaction.

[0118] EDC·HCl is incompatible with unprotected sensitive amino acids such as histidine and arginine during peptide synthesis, often resulting in side reactions or the need for additional sidechain protection strategies. These additional protective steps increase the complexity and cost of peptide synthesis. By contrast, the TBDC salts enable direct coupling of unprotected histidine, arginine, serine, threonine, tryptophan, and tyrosine residues without promoting side-chain activation, thereby simplifying synthesis and reducing processing steps.

[0119] EDC·HCl demonstrates limited effectiveness in promoting peptide bond formation in organic solvents commonly employed for liquid-phase peptide synthesis, such as DMF, ethyl acetate, or anisole. Reactions conducted with EDC·HCl in these solvents often exhibit reduced coupling efficiency, incomplete conversion, or the need for co-solvents and additives to maintain reactivity. The TBDC salts, in contrast, perform robustly in organic solvents as well as in water, thereby facilitating efficient peptide synthesis in both liquid and solid phases, without the need for extensive solvent modification.

[0120] The use of EDC and EDC·HCl as coupling reagents often results in the generation of byproducts, including urea derivatives and cyclic species, that interfere with downstream purification and analysis. These by-products can be difficult to separate from the desired peptides, particularly in organic or biphasic systems. In comparison, the TBDC salts provide clean reaction profiles with minimal generation of interfering side-products, thereby facilitating easier and more efficient purification of the final amide or peptide products.

[0121] The solubility of most commonly used CDIs coupling reagents is compared in the below table:

[0122]

[0123]

[0124] Environmental aspects:

[0125] In the context of the present invention, the use of green solvents is particularly advantageous because the coupling reagents disclosed herein, particularly the TBDC salts, demonstrate high solubility and reactivity in such solvents. This enables peptide synthesis and amide bond formation to proceed under conditions that are more environmentally sustainable compared to traditional systems reliant on toxic solvents like DMF or DCM.In the context of industrial chemistry and the present invention, a "green solvent" refers to a solvent that is designed to minimize the environmental and health impacts typically associated with traditional organic solvents. Green solvents are characterized by properties such as low toxicity, high biodegradability, low volatility, low persistence in the environment, and derivation from renewable resources whenever possible. The use of green solvents supports the principles of green chemistry, which aim to reduce hazardous chemical use and waste generation across chemical processes.

[0126] The generally accepted definition of green solvents has been shaped by international initiatives and guidelines, particularly the Twelve Principles of Green Chemistry established by Anastas and Warner. Additionally, standards and guidance provided by organizations such as the United States Environmental Protection Agency (EPA), the European Chemicals Agency (ECHA), and green solvent selection guides like the GSK solvent sustainability guide and the CHEM21 solvent selection guide are widely referenced. These standards classify solvents based on health, safety, and environmental profiles. The CHEM21 guide [Prat, D., et al. " CHEM21 selection guide of classical- and less classical-solvents: towards a greener solvent selection." Green Chemistry, 2016, 18, 288–296; doi:10.1039 / C5GC01008J], supported by the European Union, is among the most comprehensive resources and evaluates solvents based on criteria including biodegradability, toxicity, resource availability, and process safety.

[0127] The Twelve Principles of Green Chemistry provide the philosophical and practical foundation for defining what makes a solvent "green." A green solvent is one that supports these principles by being less hazardous to health and the environment, derived from renewable resources when possible, used efficiently, and readily degradable after use.

[0128] Several specific principles directly relate to the idea of green solvents:

[0129] The third principle, less hazardous chemical syntheses, ties directly into selecting solvents that are non-toxic or have reduced toxicity.

[0130] The fifth principle, safer solvents and auxiliaries, explicitly addresses solvents, recommending the use of solvents that are safe or, where possible, avoiding them altogether.

[0131] The sixth principle, design for energy efficiency, relates to solvents because solvents that allow reactions to occur at lower temperatures and pressures contribute to energy savings.

[0132] The seventh principle, use of renewable feedstocks, suggests that solvents derived from renewable resources, like bio-based solvents, are preferred.

[0133] The tenth principle, design for degradation, relates to solvents that can break down into non-toxic by-products after use rather than persisting in the environment.The twelfth principle, inherently safer chemistry for accident prevention, points toward selecting solvents that have lower flammability, explosivity, and other safety risks.

[0134] The other Principles of Green Chemistry include:

[0135] The first principle is prevention, which emphasizes that it is better to prevent waste than to treat or clean up waste after it is formed.

[0136] The second principle is atom economy, which aims for synthetic methods to maximize the incorporation of all materials used in the process into the final product.

[0137] The fourth principle is designing safer chemicals, which focuses on designing chemical products to be effective while reducing toxicity.

[0138] The eighth principle is reduce derivatives, which discourages the use of unnecessary derivatization such as blocking or protecting groups that require additional reagents and generate waste.

[0139] The ninth principle is catalysis, promoting catalytic reagents that can carry out chemical transformations efficiently in preference to stoichiometric reagents.

[0140] The eleventh principle is real-time analysis for pollution prevention, supporting the development of analytical methodologies that allow for real-time, in-process monitoring and control prior to the formation of hazardous substances.

[0141] In practice, there is no strict requirement that a solvent must meet all twelve principles to be called "green." Instead, a green solvent is usually evaluated across multiple criteria derived from the principles. Common expectations are that a green solvent should at least satisfy criteria related to low toxicity, biodegradability, low volatility, and safe handling.

[0142] Various industrial and regulatory guides, like the CHEM21 guide, the Pfizer solvent selection guide, and the GSK solvent sustainability guide, use scoring systems based on health, safety, and environmental impact. A solvent considered green must generally score well across these categories.

[0143] Thus, while not all twelve principles must be fully satisfied, a solvent is considered green when it significantly aligns with principles related to safety, environmental impact, renewability, and efficiency. In practical terms, meeting the expectations of safer use, biodegradability, low toxicity, and renewable sourcing is enough for a solvent to be recognized as green in the chemical industry.

[0144] A non-limiting list of green solvents relevant to the context of the present invention includes water, ethanol, isopropanol, methanol, ethyl acetate, isopropyl acetate, tert-butyl acetate, 2-methyltetrahydrofuran (2-MeTHF), cyclopentyl methyl ether (CPME), dimethyl carbonate (DMC), propylene carbonate, gamma-valerolactone (GVL), triethyl phosphate (TEP or TES), 1,3-dioxolane (DOS), and supercritical carbon dioxide. Solvents such as ethyl lactate and polyethylene glycol (PEG) derivatives are also considered green solvents. Among these, water is considered the ultimate green solvent because it is non-toxic, non-flammable, abundant, inexpensive, and inherently sustainable. In many cases, however, water alone may not provide the necessary solubility or reaction rate for chemical transformations, particularly in organic synthesis. In such cases, water is often used in combination with other green solvents to optimize both the chemical process and its environmental footprint.

[0145] In the present invention, the ability of the TBDC salts to function effectively in water and in mixtures of water with other green solvents offers a significant advantage over traditional coupling reagents, enabling greener and safer processes for amide bond formation. The compatibility with water-rich media allows the processes described herein to reduce or eliminate the need for hazardous solvents, thereby aligning with international green chemistry initiatives and industrial sustainability goals.

[0146] Definitions and Acronyms:

[0147] The term "isolated" as used herein refers to a material that has been separated from at least some of the components or contaminants with which it is naturally or synthetically associated. In the context of the present invention, an "isolated" coupling reagent means that the coupling reagent has been prepared and separated to a degree sufficient for its intended use in coupling reactions.

[0148] The term "isolated in a solid form" as used herein refers to a coupling reagent that, after preparation, exists in a solid state under standard conditions of temperature and pressure, such as a powder, crystalline form, or amorphous solid, and is suitable for use or storage in this form. The coupling reagent provided herein can be isolated by drying a solution therefore to afford the dry salt.

[0149] The term "isolated in a liquid solution form" as used herein refers to a coupling reagent that, after preparation, is dissolved in a solvent to form a stable solution under standard conditions of temperature and pressure, and is suitable for direct use or storage without requiring redissolution. Dissolving the isolated solid form of the coupling reagent in a solvent affords an isolated coupling reagent in a liquid solution form.

[0150] The term "open-chain carbodiimide form" as used herein refers to the structural configuration of the carbodiimide group in which the N=C=N unit is present in a linear, noncyclized form, as opposed to forming a cyclic structure through internal reaction with other functional groups of the molecule. In the context of the present invention, the coupling reagent exists substantially as the open-chain carbodiimide under storage and reaction conditions.The term "water-miscible solvent" as used herein refers to a solvent that is capable of mixing with water in all proportions, forming a homogeneous single -phase solution. Water-miscible solvents suitable for use in the present invention include, but are not limited to, acetone, dimethyl sulfoxide (DMSO), ethanol, methanol, isopropanol, propylene glycol, ethylene glycol, glycerol, acetonitrile, and mixtures thereof. In the context of the present invention, water miscible solvents do not include secondary amines.

[0151] The term "water-immiscible solvent" as used herein refers to a solvent that is substantially immiscible with water, meaning that upon mixing with water under standard conditions, two separate liquid phases form. For the purposes of the present invention, the phrase "substantially immiscible in water" means that the solvent exhibits up to 10%, 8%, 5%, 1%, 0.5%, or 0.1% miscibility in water by mass. In other words, a solvent that is 8% miscible in water will lose approximately 10% of its mass upon extraction with water. Water- immiscible solvents suitable for use in the present invention include ethyl acetate, cyclopentyl methyl ether, and other green solvents recognized as substantially immiscible with water.

[0152] Carbodiimides (CDIs);

[0153] 1 -hydroxybenzo triazole (HOB t);

[0154] 1 -hydroxy-7 -azabenzotriazole (HO At);

[0155] N, N’ -diisopropylcarbodiimide (DIC);

[0156] N, N’ -dicyclohexylcarbodiimide (DCC);

[0157] N-(3-dimetilaminopropil)-N'-etilcarbodiimide hydrogen chloride (EDC·HCl);

[0158] 1 - tert-B uty 1- 3 -ethy 1c arbodiimide (TB EC);

[0159] 3-(((ethylimino)methylene)amino)-N, N, N-trimethylpropan-l-aminium 4-methyl benzenesulfonate (QCD);

[0160] 3-(((tert-butylimino)methylene)amino)-N, N, N-trimethylpropan-l-aminium 4-methylbenzenesulfonate (TBDCTsO);

[0161] 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l-amine hydrogen chloride (TBDC·HCl);

[0162] 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l-amine 4-methylbenzenesulfonic acid (TBDC·TsOH);

[0163] N, N-dimethylformammide (DMF);

[0164] Dichloromethane (DCM);

[0165] N-cyclohexyl pyrrolidone (CHP);

[0166] N-octyl pyrrolidone (NOP);

[0167] N-butyl pyrrolidone (NBP);Dimethyl carbonate (DMC);

[0168] Ethyl acetate (EtOAc);

[0169] N, N-dimethylsulfoxide (DMSO);

[0170] Propyl acetate (PrOAc);

[0171] Iso-propyl acetate (iPrOAc);

[0172] Tert-butyl acetate (tBuOAc);

[0173] Cyclopentyl methyl ether (CPME); 2-Methyltetrahydrofuran (2-MeTHF); y- valerolactone (GVL);

[0174] 1,3-dioxolane (DOS);

[0175] Triethyl phosphate (TES);

[0176] Fluorenylmethoxy carbonyl (Fmoc); Tert-butoxycarbonyl (Boc);

[0177] Arginine (Arg);

[0178] Histidine (His);

[0179] Threonine (Thr);

[0180] Alanine (Ala);

[0181] Tryptophan (Trp);

[0182] Serine (Ser);

[0183] Leucine (Leu);

[0184] Lysine (Lys);

[0185] Methionine (Met);

[0186] Phenylalanine (Phe);

[0187] Tyrosine (Tyr);

[0188] Glycine (Gly);

[0189] Valine (Val);

[0190] Isoleucine (Ile);

[0191] Proline (Pro);

[0192] Aspartic acid (Asp);

[0193] Glutamic acid (Glu);

[0194] Asparagine (Asn);

[0195] Glutamine (Gin); and

[0196] Cysteine (Cys).As used herein the term “about” or “approximately,” refers to ±10 %. For example, the term “about 100 units” encompasses the value 100 units, as well as the values 90 units, 91 units, 92 units, 93 units, 94 units, 95 units, 96 units, 97 units, 98 units, 98 units, 99 units, 100 units, 101 units, 102 units, 103 units, 104 units, 105 units, 106 units, 107 units, 108 units, 109 units, and 110 units.

[0197] The terms "comprises", "comprising", "includes", "including", “having” and their conjugates mean "including but not limited to"; namely, as used herein, these terms are intended to be open-ended and not limiting. They indicate that the presence of the listed elements does not preclude the inclusion of additional, unrecited elements or method steps.

[0198] The term “consisting of’ means “including and limited to”.

[0199] The term "consisting essentially of" means that the composition, method or structure may include additional ingredients, steps and / or parts, but only if the additional ingredients, steps and / or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.

[0200] The phrase “one or more” as used herein includes one, two, three, or more of the described elements or components and does not exclude any combinations or sub-combinations thereof.

[0201] The terms “preferred” or “preferably” indicate an example or embodiment that is more suitable or favorable under certain circumstances, but these terms are not intended to limit the scope of the invention or to suggest that other variations are excluded.

[0202] As used herein, the phrase “selected from the group consisting of’ includes all members of the recited group, each member of the recited group, and all possible combinations. For example, selected from the group consisting of A, B, and C, includes A, only, as well as B, only, as well as C, only, as well as A and B, as well as A and C, as well as B and C, and as well as A, B, and C.

[0203] The term “substantially,” when used in reference to a characteristic or parameter, means that the characteristic or parameter need not be absolute but is close enough to the specified value or condition so as to achieve the intended purpose or effect.

[0204] As used herein, the phrases "substantially devoid of" and / or "essentially devoid of" in the context of a certain substance, refer to a composition that is totally devoid of this substance or includes less than about 5, 1, 0.5 or 0.1 percent of the substance by total weight or volume of the composition. Alternatively, the phrases "substantially devoid of" and / or "essentially devoid of" in the context of a process, a method, a property or a characteristic, refer to a process, a composition, a structure or an article that is totally devoid of a certain process / method step, or a certain property or a certain characteristic, or a process / method wherein the certain process / method step is effected at less than about 5, 1, 0.5 or 0.1 percent compared to a given standard process / method, or propertyor a characteristic characterized by less than about 5, 1, 0.5 or 0.1 percent of the property or characteristic, compared to a given standard. Further alternatively, the terms "substantially" and / or "essentially " in the context of a characterizing property, means that the characterizing property is expressed to at least 99 %, at least 95 %, at least 90 % of its full or complete expression. For example, the phrase “the elements are maintained substantially in a certain configuration” should be read as “at least 99 % of the elements are maintained in the certain configuration.”

[0205] As used herein, the phrases "substantially devoid of" and / or "essentially devoid of" in the context of a certain substance, refer to a composition that is totally devoid of this substance or includes less than about 5, 1, 0.5 or 0.1 percent of the substance by total weight or volume of the composition. Alternatively, the phrases "substantially devoid of" and / or "essentially devoid of" in the context of a process, a method, a property or a characteristic, refer to a process, a composition, a structure or an article that is totally devoid of a certain process / method step, or a certain property or a certain characteristic, or a process / method wherein the certain process / method step is effected at less than about 5, 1, 0.5 or 0.1 percent compared to a given standard process / method, or property or a characteristic characterized by less than about 5, 1, 0.5 or 0.1 percent of the property or characteristic, compared to a given standard.

[0206] When applied to an original property, or a desired property, or an afforded property of an object or a composition, the term “substantially maintaining”, as used herein, means that the property has not change by more than 20 %, 10 % or more than 5 % in the processed object or composition.

[0207] When applied to the term “substantially immiscible in water”, it means that the solvent in question exhibits up to 10, 8, 5, 1, 0.5 or 0.1 percent miscibility in water. In other words, in the case of a solvent that is 8 % miscible in water, the solvent’s mass will lose 10 % of its mass by washing the solvent with water.

[0208] The term “exemplary” is used herein to mean “serving as an example, instance or illustration”. Any embodiment described as “exemplary” is not necessarily to be construed as preferred or advantageous over other embodiments and / or to exclude the incorporation of features from other embodiments.

[0209] The words “optionally” or “alternatively” are used herein to mean “is provided in some embodiments and not provided in other embodiments”. Any particular embodiment of the invention may include a plurality of “optional” features unless such features conflict.

[0210] As used herein, the singular form "a", "an" and "the" include plural references unless the context clearly dictates otherwise. For example, the term "a compound" or "at least one compound" may include a plurality of compounds, including mixtures thereof.Throughout this application, various embodiments of this invention may be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.

[0211] Whenever a numerical range is indicated herein, it is meant to include any cited numeral (fractional or integral) within the indicated range. The phrases “ranging / ranges between” a first indicate number and a second indicate number and “ranging / ranges from” a first indicate number “to” a second indicate number are used herein interchangeably and are meant to include the first and second indicated numbers and all the fractional and integral numerals therebetween.

[0212] As used herein the terms “process” and "method" refer to manners, means, techniques and procedures for accomplishing a given task including, but not limited to, those manners, means, techniques and procedures either known to, or readily developed from known manners, means, techniques and procedures by practitioners of the chemical, material, mechanical, computational and digital arts.

[0213] Terms used in the singular form shall also include the plural, and vice versa, unless context clearly indicates otherwise. Furthermore, words of any gender include all genders and are intended to cover all corresponding terms.

[0214] Unless otherwise defined, all technical and / or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of embodiments of the invention, exemplary methods and / or materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and are not intended to be necessarily limiting.

[0215] General chemistry definitions:

[0216] Definitions of specific functional groups, chemical terms, and general terms used throughout the specification are described in more detail below. For purposes of this invention, the chemical elements are identified in accordance with the Periodic Table of the Elements, CAS version, Handbook of Chemistry and Physics, 75thEd., inside cover, and specific functional groupsare generally defined as described therein. Additionally, general principles of organic chemistry, as well as specific functional moieties and reactivity, are described in Organic Chemistry, Thomas Sorrell, University Science Books, Sausalito, 1999; Smith and March March's Advanced Organic Chemistry, 5thEdition, John Wiley & Sons, Inc., New York, 2001; Larock, Comprehensive Organic Transformations, VCH Publishers, Inc., New York, 1989; Carruthers, Some Modern Methods of Organic Synthesis, 3rdEdition, Cambridge University Press, Cambridge, 1987.

[0217] As used herein, the terms “amine” or ’’amino”, describe both a -NR’R” end group and a -NR'- linking moiety, wherein R’ and R" are each independently hydrogen, alkyl, cycloalkyl, aryl, as these terms are defined hereinbelow.

[0218] The amine group can therefore be a primary amine, where both R’ and R” are hydrogen, a secondary amine, where R’ is hydrogen and R” is alkyl, cycloalkyl or aryl, or a tertiary amine, where each of R’ and R” is independently alkyl, cycloalkyl or aryl.

[0219] Alternatively, R' and R" can each independently be hydrogen, hydroxyalkyl, trihaloalkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, heteroalicyclic, amine, halo, sulfonate, sulfoxide, phosphonate, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, nitro, azo, azido, sulfonamide, carbonyl, C-carboxylate, O-carboxylate, N-thiocarbamate, O-thiocarbamate, urea, thiourea, N-carbamate, O-carbamate, C-amide, N-amide, guanyl, guanidine and hydrazine, as these terms are defined herein.

[0220] The term "alkyl" describes a saturated aliphatic hydrocarbon including straight chain (unbranched) and branched chain groups. Preferably, the alkyl group has 1 to 20 carbon atoms. Whenever a numerical range; e.g., "1-20", is stated herein, it implies that the group, in this case the alkyl group, may contain 1 carbon atom, 2 carbon atoms, 3 carbon atoms, etc., up to and including 20 carbon atoms. More preferably, the alkyl is a medium size alkyl having 1 to 10 carbon atoms. Most preferably, unless otherwise indicated, the alkyl is a lower alkyl having 1 to 4 carbon atoms. The alkyl group may be substituted or unsubstituted. Substituted alkyl may have one or more substituents, whereby each substituent group can independently be, for example, hydroxyalkyl, trihaloalkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, heteroalicyclic, amine, halo, sulfonate, sulfoxide, phosphonate, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, nitro, azo, azido, sulfonamide, C-carboxylate, O-carboxylate, N-thiocarbamate, O-thiocarbamate, urea, thiourea, N-carbamate, O-carbamate, C-amide, N-amide, guanyl, guanidine and hydrazine.

[0221] The alkyl group can be an end group, as this phrase is defined hereinabove, wherein it is attached to a single adjacent atom, or a linking moiety, as this phrase is defined hereinabove, whichconnects two or more moieties via at least two carbons in its chain. When an alkyl is a linking moiety, it is also referred to herein as “alkylene”, e.g., methylene, ethylene, propylene, etc.

[0222] The term "alkenyl" describes an unsaturated alkyl, as defined herein, having at least two carbon atoms and at least one carbon-carbon double bond. The alkenyl may be substituted or unsubstituted by one or more substituents, as described for alkyl hereinabove.

[0223] The terms "alkynyl" or "alkyne", as defined herein, is an unsaturated alkyl having at least two carbon atoms and at least one carbon-carbon triple bond. The alkynyl may be substituted or unsubstituted by one or more substituents, as described hereinabove.

[0224] The term "cycloalkyl" describes an all-carbon monocyclic or fused ring (i.e., rings that share an adjacent pair of carbon atoms) group where one or more of the rings does not have a completely conjugated pi-electron system. The cycloalkyl group may be substituted or unsubstituted. Substituted cycloalkyl may have one or more substituents, whereby each substituent group can independently be, for example, hydroxyalkyl, trihaloalkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, heteroalicyclic, amine, halo, sulfonate, sulfoxide, phosphonate, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, nitro, azo, azido, sulfonamide, C-carboxylate, O-carboxylate, N-thiocarbamate, O-thiocarbamate, urea, thiourea, N-carbamate, O-carbamate, C-amide, N-amide, guanyl, guanidine and hydrazine. The cycloalkyl group can be an end group, as this phrase is defined hereinabove, wherein it is attached to a single adjacent atom, or a linking moiety, as this phrase is defined hereinabove, connecting two or more moieties at two or more positions thereof.

[0225] The term "heteroalicyclic" describes a monocyclic or fused ring group having in the ring(s) one or more atoms such as nitrogen, oxygen and sulfur. The rings may also have one or more double bonds. However, the rings do not have a completely conjugated pi-electron system. The heteroalicyclic may be substituted or unsubstituted. Substituted heteroalicyclic may have one or more substituents, whereby each substituent group can independently be, for example, hydroxyalkyl, trihaloalkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, heteroalicyclic, amine, halo, sulfonate, sulfoxide, phosphonate, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, nitro, azo, azido, sulfonamide, C-carboxylate, O-carboxylate, N-thiocarbamate, O-thiocarbamate, urea, thiourea, O-carbamate, N-carbamate, C-amide, N-amide, guanyl, guanidine and hydrazine. The heteroalicyclic group can be an end group, as this phrase is defined hereinabove, where it is attached to a single adjacent atom, or a linking moiety, as this phrase is defined hereinabove, connecting two or more moieties at two or more positions thereof. Representative examples are piperidine, piperazine, tetrahydrofurane, tetrahydropyrane, morpholino and the like.The term "aryl" describes an all-carbon monocyclic or fused-ring polycyclic (i.e., rings which share adjacent pairs of carbon atoms) groups having a completely conjugated pi-electron system. The aryl group may be substituted or unsubstituted. Substituted aryl may have one or more substituents, whereby each substituent group can independently be, for example, hydroxyalkyl, trihaloalkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, heteroalicyclic, amine, halo, sulfonate, sulfoxide, phosphonate, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, nitro, azo, azido, sulfonamide, C-carboxylate, O-carboxylate, N-thiocarbamate, O-thiocarbamate, urea, thiourea, N-carbamate, O-carbamate, C-amide, N-amide, guanyl, guanidine and hydrazine. The aryl group can be an end group, as this term is defined hereinabove, wherein it is attached to a single adjacent atom, or a linking moiety, as this term is defined hereinabove, connecting two or more moieties at two or more positions thereof. Preferably, the aryl is phenyl.

[0226] The term "heteroaryl" describes a monocyclic or fused ring (i.e., rings which share an adjacent pair of atoms) group having in the ring(s) one or more atoms, such as, for example, nitrogen, oxygen and sulfur and, in addition, having a completely conjugated pi-electron system. Examples, without limitation, of heteroaryl groups include pyrrole, furane, thiophene, imidazole, oxazole, thiazole, pyrazole, pyridine, pyrimidine, quinoline, isoquinoline and purine. The heteroaryl group may be substituted or unsubstituted. Substituted heteroaryl may have one or more substituents, whereby each substituent group can independently be, for example, hydroxyalkyl, trihaloalkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, heteroalicyclic, amine, halo, sulfonate, sulfoxide, phosphonate, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, nitro, azo, azido, sulfonamide, C-carboxylate, O-carboxylate, N-thiocarbamate, O-thiocarbamate, urea, thiourea, O-carbamate, N-carbamate, C-amide, N-amide, guanyl, guanidine and hydrazine. The heteroaryl group can be an end group, as this phrase is defined hereinabove, where it is attached to a single adjacent atom, or a linking moiety, as this phrase is defined hereinabove, connecting two or more moieties at two or more positions thereof. Representative examples are pyridine, pyrrole, oxazole, indole, purine and the like.

[0227] The term “alkaryl” describes an alkyl, as defined herein, which is substituted by one or more aryl or heteroaryl groups. An example of alkaryl is benzyl.

[0228] The term "amine-oxide” describes a -N(OR’)(R”) or a -N(OR')- group, where R’ and R” are as defined herein. This term refers to a -N(OR')(R") group in cases where the amine-oxide is an end group, as this phrase is defined hereinabove, and to a -N(OR')- group in cases where the amine-oxime is an end group, as this phrase is defined hereinabove.As used herein, the term “acyl” refers to a group having the general formula -C(=O)R’, -C(=O)OR’, -C(=O)-O-C(=O)R’, -C(=O)SR’, -C(=O)N(R’)2, -C(=S)R’, -C(= S)N(R’)2, and -C(=S)S(R’), -C(=NR’)R”, -C(=NR’)OR”, -C(=NR’)SR”, and -C(=NR’)N(R”)2, wherein R’ and R” are each independently hydrogen, halo, substituted or unsubstituted hydroxyl, substituted or unsubstituted thiol, substituted or unsubstituted amine, substituted or unsubstituted acyl, cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic, cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic, cyclic or acyclic, substituted or unsubstituted, branched or unbranched alkyl, cyclic or acyclic, substituted or unsubstituted, branched or unbranched alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, aliphaticoxy, heteroaliphaticoxy, alkyloxy, heteroalkyloxy, aryloxy, hetero aryloxy, aliphaticthioxy, heteroaliphaticthioxy, alkylthioxy, heteroalkylthioxy, arylthioxy, heteroarylthioxy, mono- or di-aliphaticamino, mono-or di-heteroaliphaticamino, mono- or di- alkylamino, mono- or di-heteroalkylamino, mono- or diarylamino, or mono- or di-heteroarylamino; or two RX1groups taken together form a 5- to 6-membered heterocyclic ring. Exemplary acyl groups include aldehydes (-CHO), carboxylic acids (-CO2H), ketones, acyl halides, esters, amides, imines, carbonates, carbamates, and ureas. Acyl substituents include, but are not limited to, any of the substituents described herein, that result in the formation of a stable moiety (e.g., aliphatic, alkyl, alkenyl, alkynyl, heteroaliphatic, heterocyclic, aryl, heteroaryl, acyl, oxo, imino, thioxo, cyano, isocyano, amino, azido, nitro, hydroxyl, thiol, halo, aliphaticamino, heteroaliphaticamino, alkylamino, heteroalkylamino, arylamino, heteroarylamino, alkylaryl, arylalkyl, aliphaticoxy, heteroaliphaticoxy, alkyloxy, heteroalkyloxy, aryloxy, hetero aryloxy, aliphaticthioxy, heteroaliphaticthioxy, alkylthioxy, heteroalkylthioxy, arylthioxy, heteroarylthioxy, acyloxy, and the like, each of which may or may not be further substituted).

[0229] As used herein, the term “aliphatic” or “aliphatic group” denotes an optionally substituted hydrocarbon moiety that may be straight-chain (i.e., unbranched), branched, or cyclic (“carbocyclic”) and may be completely saturated or may contain one or more units of unsaturation, but which is not aromatic. Unless otherwise specified, aliphatic groups contain 1-12 carbon atoms. In some embodiments, aliphatic groups contain 1-6 carbon atoms. In some embodiments, aliphatic groups contain 1-4 carbon atoms, and in yet other embodiments aliphatic groups contain 1-3 carbon atoms. Suitable aliphatic groups include, but are not limited to, linear or branched, alkyl, alkenyl, and alkynyl groups, and hybrids thereof such as (cycloalkyl)alkyl, (cycloalkenyl)alkyl or (cycloalkyl)alkenyl.As used herein, the terms “heteroaliphatic” or “heteroaliphatic group”, denote an optionally substituted hydrocarbon moiety having, in addition to carbon atoms, from one to five heteroatoms, that may be straight-chain (i.e., unbranched), branched, or cyclic (“heterocyclic”) and may be completely saturated or may contain one or more units of unsaturation, but which is not aromatic. Unless otherwise specified, heteroaliphatic groups contain 1-6 carbon atoms wherein 1-3 carbon atoms are optionally and independently replaced with heteroatoms selected from oxygen, nitrogen and sulfur. In some embodiments, heteroaliphatic groups contain 1-4 carbon atoms, wherein 1-2 carbon atoms are optionally and independently replaced with heteroatoms selected from oxygen, nitrogen and sulfur. In yet other embodiments, heteroaliphatic groups contain 1-3 carbon atoms, wherein 1 carbon atom is optionally and independently replaced with a heteroatom selected from oxygen, nitrogen and sulfur. Suitable heteroaliphatic groups include, but are not limited to, linear or branched, heteroalkyl, heteroalkenyl, and heteroalkynyl groups.

[0230] The term “halo” describes fluorine, chlorine, bromine or iodine substituent.

[0231] The term "halide" describes an anion of a halogen atom, namely F“, Cl’ Br“ and T.

[0232] The term “haloalkyl” describes an alkyl group as defined above, further substituted by one or more halide.

[0233] The term “sulfate” describes a -O-S(=O)2-OR’ end group, as this term is defined hereinabove, or an -O-S (=0)2-0- linking moiety, as these phrases are defined hereinabove, where R’ is as defined hereinabove.

[0234] The term “thiosulfate” describes a -O-S(=S)(=O)-OR’ end group or a -O-S(=S)(=O)-O-linking moiety, as these phrases are defined hereinabove, where R’ is as defined hereinabove.

[0235] The term “sulfite” describes an -O-S(=O)-O-R’ end group or a -O-S(=O)-O- group linking moiety, as these phrases are defined hereinabove, where R’ is as defined hereinabove.

[0236] The term “thiosulfite” describes a -O-S(=S)-O-R’ end group or an -O-S(=S)-O- group linking moiety, as these phrases are defined hereinabove, where R’ is as defined hereinabove.

[0237] The term “sulfinate” or “sulfinyl” describes a -S(=O)-OR’ end group or an -S(=O)-O-group linking moiety, as these phrases are defined hereinabove, where R’ is as defined hereinabove.

[0238] The terms “solfoxide” or “sulfinyl” describe a -S(=O)R’ end group or an -S(=O)- linking moiety, as these phrases are defined hereinabove, where R’ is as defined hereinabove.

[0239] The term "sulfonate” or “sulfonyl” describes a -S(=O)2-R’ end group or an -S(=O)2-linking moiety, as these phrases are defined hereinabove, where R’ is as defined herein.

[0240] The term “S-sulfonamide” describes a -S(=O)2-NR’R” end group or a -S(=O)2-NR’-linking moiety, as these phrases are defined hereinabove, with R’ and R’ ’ as defined herein.The term " N-sulfonamide" describes an R’S(=O)2-NR”- end group or a -S(=O)2-NR’-linking moiety, as these phrases are defined hereinabove, where R’ and R’ ’ are as defined herein.

[0241] The term “disulfide” refers to a -S-SR’ end group or a -S-S- linking moiety, as these phrases are defined hereinabove, where R’ is as defined herein.

[0242] The term “phosphate” describes an -O-P(=O)2(OR’) end or reactive group or a -O-P(=O)2(O)- linking moiety, as these phrases are defined hereinabove, with R’ as defined herein.

[0243] The term “phosphonate” describes a -P(=O)(OR’)(OR”) end or reactive group or a -P(=O)(OR’)(O)- linking moiety, as these phrases are defined hereinabove, with R’ and R” as defined herein.

[0244] The term “thiophosphonate” describes a -P(=S)(OR’)(OR”) end group or a -P(=S)(OR’)(O)- linking moiety, as these phrases are defined hereinabove, with R’ and R” as defined herein.

[0245] The term "carbonyl" or "carbonate" as used herein, describes a -C(=O)-R’ end group or a -C(=O)- linking moiety, as these phrases are defined hereinabove, with R’ as defined herein.

[0246] The term "thiocarbonyl" as used herein, describes a -C(=S)-R’ end group or a -C(=S)-linking moiety, as these phrases are defined hereinabove, with R’ as defined herein.

[0247] The term “oxo” as used herein, described a =0 end group.

[0248] The term “thioxo” as used herein, described a =S end group.

[0249] The term “oxime” describes a =N-0H end group or a =N-O- linking moiety, as these phrases are defined hereinabove.

[0250] The term “hydroxyl” describes a -OH group.

[0251] As used herein, the term “aldehyde” refers to an -C(=O)-H group.

[0252] The term “acyl halide” describes a -(C=O)R"" group wherein R"" is halo, as defined hereinabove.

[0253] The term “alkoxy” as used herein describes an -O-alkyl, an -O-cycloalkyl, as defined hereinabove. The ether group -O- is also a possible linking moiety.

[0254] The term "aryloxy" describes both an -O-aryl and an -O-heteroaryl group, as defined herein.

[0255] The term “disulfide” as used herein describes an -S-S- linking moiety, which in some cases forms between two thiohydroxyl groups.

[0256] The terms “thio”, "sulfhydryl" or "thiohydroxyl" as used herein describe an -SH group. The term "thioalkoxy" or “thioether” describes both a -S-alkyl group, and a -S-cycloalkyl group, as defined herein. The thioether group -S- is also a possible linking moiety.The term "thioaryloxy" describes both a -S-aryl and a -S-heteroaryl group, as defined herein. The thioarylether group -S-aryl- is also a possible linking moiety.

[0257] The term "cyano" or “nitrile” describes a -C=N group.

[0258] The term “isocyanate” describes an -N=C=O group.

[0259] The term "nitro" describes an -NO2 group.

[0260] The term “carboxylate” or "ester", as used herein encompasses C-carboxylate and O-carboxylate.

[0261] The term “C-carboxylate” describes a -C(=O)-OR’ end group or a -C(=O)-O- linking moiety, as these phrases are defined hereinabove, where R’ is as defined herein.

[0262] The term “O-carboxylate” describes a -OC(=O)R’ end group or a -OC(=O)- linking moiety, as these phrases are defined hereinabove, where R’ is as defined herein.

[0263] The term “thiocarboxylate” as used herein encompasses “C-thiocarboxylate and O-thiocarboxylate.

[0264] The term “C-thiocarboxylate” describes a -C(=S)-OR’ end group or a -C(=S)-O- linking moiety, as these phrases are defined hereinabove, where R’ is as defined herein.

[0265] The term “O-thiocarboxylate” describes a -OC(=S)R’ end group or a -OC(=S)- linking moiety, as these phrases are defined hereinabove, where R’ is as defined herein.

[0266] The term “carbamate” as used herein encompasses N-carbamate and O-carbamate.

[0267] The term “N-carbamate” describes an R”OC(=O)-NR’- end group or a -OC(=O)-NR’-linking moiety, as these phrases are defined hereinabove, with R’ and R” as defined herein.

[0268] The term “O-carbamate” describes an -OC(=O)-NR’R” end group or an -OC(=O)-NR’- linking moiety, as these phrases are defined hereinabove, with R’ and R” as defined herein.

[0269] The term “thiocarbamate” as used herein encompasses N-thiocarbamate and O-thiocarbamate.

[0270] The term “O-thiocarbamate” describes a -OC(=S)-NR’R” end group or a -OC(=S)-NR’- linking moiety, as these phrases are defined hereinabove, with R’ and R” as defined herein.

[0271] The term “N-thiocarbamate” describes an R”OC(=S)NR’- end group or a -OC(=S)NR’-linking moiety, as these phrases are defined hereinabove, with R’ and R” as defined herein.

[0272] The term “dithiocarbamate” as used herein encompasses N-dithiocarbamate and S-dithiocarbamate.

[0273] The term “S -dithiocarbamate” describes a -SC(=S)-NR’R” end group or a -SC(=S)NR’- linking moiety, as these phrases are defined hereinabove, with R’ and R” as defined herein.The term “N-dithiocarbamate” describes an R”SC(=S)NR’- end group or a -SC(=S)NR’-linking moiety, as these phrases are defined hereinabove, with R’ and R” as defined herein.

[0274] The term "urea", which is also referred to herein as “ureido”, describes a -NR’C(=O)-NR”R’” end group or a -NR’C(=O)-NR”- linking moiety, as these phrases are defined hereinabove, where R’ and R” are as defined herein and R'" is as defined herein for R' and R".

[0275] The term “thiourea”, which is also referred to herein as “thioureido”, describes a -NR’-C(=S)-NR”R”’ end group or a -NR’-C(=S)-NR”- linking moiety, with R’, R” and R”’ as defined herein.

[0276] The term “amide” as used herein encompasses C-amide and N-amide.

[0277] The term “C-amide” describes a -C(=O)-NR’R” end group or a -C(=O)-NR’- linking moiety, as these phrases are defined hereinabove, where R’ and R” are as defined herein.

[0278] The term “N-amide” describes a R’C(=O)-NR”- end group or a R’C(=O)-N- linking moiety, as these phrases are defined hereinabove, where R’ and R” are as defined herein.

[0279] The term “imine”, which is also referred to in the art interchangeably as “Schiff-base”, describes a -N=CR'- linking moiety, with R' as defined herein or hydrogen. As is well known in the art, Schiff bases are typically formed by reacting an aldehyde or a ketone and an amine-containing moiety such as amine, hydrazine, hydrazide and the like, as these terms are defined herein. The term “aldimine" refers to a -CH=N- imine which is derived from an aldehyde. The term “ketimine" refers to a -CR-N- imine which is derived from a ketone.

[0280] The term “hydrazone" refers to a -R'C=N-NR”- linking moiety, wherein R’ and R” are as defined herein.

[0281] The term “semicarbazone" refers to a linking moiety which forms in a condensation reaction between an aldehyde or ketone and semicarbazide. A semicarbazone linking moiety stemming from a ketone is a -R'C=NNR" C(=O)NR"'-, and a linking moiety stemming from an aldehyde is a -CR'=NNR" C(=O)NR"'-, wherein R’ and R” are as defined herein and R'" or as defined for R’.

[0282] As used herein, the term "lactone" refers to a cyclic ester, namely the intra-condensation product of an alcohol group -OH and a carboxylic acid group -COOH in the same molecule.

[0283] As used herein, the term "lactam" refers to a cyclic amide, as this term is defined herein. A lactam with two carbon atoms beside the carbonyl and four ring atoms in total is referred to as a P-lactam, a lactam with three carbon atoms beside the carbonyl and five ring atoms in total is referred to as a y-lactam, a lactam with four carbon atoms beside the carbonyl and six ring atoms in total is referred to as a 5-lactam, and so on.The term “guanyl” describes a R’R”NC(=N)- end group or a -R’NC(=N)- linking moiety, as these phrases are defined hereinabove, where R’ and R” are as defined herein.

[0284] The term “guanidine” describes a -R’NC(=N)-NR”R”’ end group or a -R’NC(=N)- NR”- linking moiety, as these phrases are defined hereinabove, where R’, R" and R'" are as defined herein.

[0285] The term “hydrazine” describes a -NR’-NR”R”’ end group or a -NR’-NR”- linking moiety, as these phrases are defined hereinabove, with R’, R”, and R'" as defined herein.

[0286] As used herein, the term “hydrazide” describes a -C(=O)-NR’-NR”R”’ end group or a -C(=O)-NR’-NR”- linking moiety, as these phrases are defined hereinabove, where R’, R” and R’” are as defined herein.

[0287] The term "hydroxylamine", as used herein, refers to either a -NHOH group or a -ONH2. As used herein, the terms “azo” or “diazo” describe a -N=N-R’ end group or a -N=N-linking moiety, as these phrases are defined hereinabove, where R’ is as defined herein.

[0288] As used herein, the term “azido” described a -N=N+=N“ (-N3) end group.

[0289] The term “triazine" refers to a heterocyclic ring, analogous to the six-membered benzene ring but with three carbons replaced by nitrogen atoms. The three isomers of triazine are distinguished from each other by the positions of their nitrogen atoms, and are referred to as 1,2,3-triazine, 1,2,4-triazine, and 1,3,5-triazine. Other aromatic nitrogen heterocycles include pyridines with 1 ring nitrogen atom, diazines with 2 nitrogen atoms in the ring and tetrazines with 4 ring nitrogen atoms.

[0290] The term "triazole" refers to either one of a pair of isomeric chemical compounds with molecular formula C2H3N3, having a five-membered ring of two carbon atoms and three nitrogen atoms, namely 1,2,3-triazoles and 1,2,4-triazoles.

[0291] The term “aziridine", as used herein, refers to a reactive group which is a three membered heterocycle with one amine group and two methylene groups, having a molecular formula of -C2H3NH.

[0292] As used herein, the term “thiohydrazide” describes a -C(=S)-NR’-NR”R”’ end group or a -C(=S)-NR’-NR”- linking moiety, as these phrases are defined hereinabove, where R’, R” and R’” are as defined herein.

[0293] As used herein, the term “methyleneamine” describes an -NR’-CH2-CH=CR”R”’ end group or a -NR’-CH2-CH=CR”- linking moiety, as these phrases are defined hereinabove, where R’, R” and R’” are as defined herein.

[0294] The term "diene", as used herein, refers to a -CR'=CR"-CR"'=CR""- group, wherein R’ as defined hereinabove, and R", R'" and R"" are as defined for R'.The term "dienophile", as used herein, refers to a reactive group that reacts with a diene, typically in a Diels-Alder reaction mechanism, hence a dienophile is typically a double bond or an alkenyl.

[0295] The term “epoxy", as used herein, refers to a reactive group which is a three membered heterocycle with one oxygen and two methylene groups, having a molecular formula of -C2H3O.

[0296] The phrase "covalent bond", as used herein, refers to one or more pairs of electrons that are shared between atoms in a form of chemical bonding.

[0297] It is expected that during the life of a patent maturing from this application many relevant TBDC salt coupling reagents and methods for amide bond formation using the same will be developed and the scope of the phrase " TBDC salt coupling reagents and methods for amide bond formation" is intended to include all such new technologies a priori.

[0298] It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.

[0299] Various embodiments and aspects of the present invention as delineated hereinabove and as claimed in the claims section below find experimental support in the following examples.

[0300] EXAMPLES

[0301] Reference is now made to the following examples, which together with the above descriptions, illustrate some embodiments of the invention in a non-limiting fashion.

[0302] EXAMPLE 1

[0303] Coupling Reaction Between Phenylglycine and Prolinamide in Solution A coupling reaction was performed between phenylglycine and prolinamide using various carbodiimides as coupling reagents. The reactions were carried out in solution at 30 °C using 1.5 equivalents of carbodiimide and 1.5 equivalents of OxymaPure relative to Fmoc-phenylglycine.

[0304] The carbodiimides tested included tert-butyl ethylcarbodiimide (TBEC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl), and the pre-formed salts 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l-amine hydrochloride (TBDC·HCl) and 4-methylbenzenesulfonic acid salt (TBDC·TsOH). The free base of TBDC was also combined withvarious acids including methanesulfonic acid, phenylsulfonic acid, trifluoroacetic acid, trichloroacetic acid, and 3, 5 -dinitrobenzoic acid.

[0305] The conversion percentage were demonstrated by the reaction presented in Scheme 1, L: D enantiomeric ratios were determined by HPLC analysis after one hour, and the results are summarized in Table 1, presenting coupling test between phenylglycine and prolinamide, forming (9H-fluoren-9-yl)methyl ((S)-2-((S)-2-carbamoylpyrrolidin-l-yl)-2-oxo-l-phenylethyl)carbamate (3).

[0306] Scheme 1

[0307]

[0308] Table 1

[0309]

[0310] The coupling with free TBDC base and added acid was less efficient or led to impurities, whereas the pre-formed TBDC salts (HC1 and TsOH) gave excellent conversion and stereoselectivity.EXAMPLE 2

[0311] Coupling ofFmoc-Histidine Without Side-Chain Protection

[0312] Coupling reactions were performed between Fmoc-histidine and an amine using different carbodiimide salts. The reactions were conducted at room temperature in DMF using 2 equivalents of carbodiimide and 2 equivalents of OxymaPure relative to Fmoc-histidine.

[0313] Conversion percentages and the amount of side-chain activation product (B) were analyzed by HPLC. Results are summarized in Table 2, presenting free side-chain protective groups, histidine coupling.

[0314]

[0315] Table 2

[0316]

[0317] TBEC provided almost complete coupling. EDC·HCl promoted full conversion but significant side-chain activation. Only TBDC·HCl and TBDC-TsOH afforded complete conversion without measurable side reactions. The protocol was used for the synthesis in SPPS in DMF for the peptide below confirmed the compatibility with arginine, histidine, thriptophane and threonine.EXAMPLE 3

[0318] Solid-Phase Synthesis of a Model Peptide (Thr-His-Ala-Arg-Trp-Ser-Leu) A model heptapeptide with the sequence Thr-His-Ala-Arg-Trp-Ser-Leu was synthesized using TBDC·HCl in SPPS. The synthesis was performed in DMF using a Wang resin without the use of side-chain protecting groups for arginine, histidine, or tryptophan.

[0319]

[0320] Table 3

[0321]

[0322] As can be seen in Table 3, after final cleavage and deprotection, HPLC analysis showed a target peptide purity of 95.7%. The major impurities were des-Arg-des-His (3.7%) and des-Arg-His (0.6%). No coupling at the free side-chain of histidine was observed, meaning the histidine residue need not be protected.

[0323] EXAMPLE 4

[0324] NMR Analysis of Carbodiimides to Confirm Open Structures1H-NMR analysis was performed to investigate the structural stability of EDC·HCl, TBDC·HCl, and TBDC·TsOH. Spectra were recorded in D2O at 25 °C (spectra not shown, but available upon request).

[0325] The1H-NMR spectra confirmed that EDC·HCl exists as an equilibrium mixture of open and cyclic forms, whereas both TBDC·HCl and TBDC·TsOH exist exclusively in the open-chain carbodiimide structure, with no evidence of cyclization.Characteristic CH₃ and CH₂ signals confirmed the open structure stability of the TBDC salts.

[0326] EXAMPLE 5

[0327] NMR Determination of the Stoichiometric Ratio in TBDC-TsOH The stoichiometric ratio between TBDC and p-toluenesulfonic acid in the pre-formed salt TBDC-TsOH was determined by ¹H-NMR (spectra not shown, but available upon request).

[0328] The analysis revealed an approximately perfect 1:1 molar ratio between the carbodiimide and the acid, ensuring consistent composition for synthetic applications.

[0329] The ¹H-NMR analysis confirmed that TBDC and p-toluenesulfonic acid exist in approximately a 1:1 molar ratio within the salt, ensuring consistent stoichiometry.

[0330] EXAMPLE 6

[0331] General SPPS Procedure

[0332] Salts of 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l -amine (TBDC) were prepared as described herein and utilized in solid-phase peptide synthesis (SPPS) as coupling reagents. In a typical procedure, the TBDC salt (4.5 to 7.5 equivalents relative to the resin loading) was mixed with Fmoc-AAY-OH (3 to 5 equivalents) and a coupling additive (3 to 5 equivalents), such as OxymaPure, 1 -hydroxybenzotriazole (HOBt), 1-hydroxy-7-azabenzotriazole (HOAt), 1-hydroxy-6-oxo-lH-benzotriazole (HOOBt), or l-hydroxy-7-oxo-lH-pyrrolo[2,3-b]pyridine (HOPO), dissolved in a corresponding solvent. The reaction mixture was prepared either in the presence or absence of a tertiary base such as diisopropylethylamine (DIEA) or triethylamine (TEA) in amounts of 4.5 to 7.5 equivalents. A tertiary base was used in cases where the amino acid building block was salified, for example, as an HC1 salt, to deprotonate the amine group and facilitate nucleophilic coupling.

[0333] The mixture was stirred for a period of 1 to 10 minutes to allow activation, and subsequently added to the amino-functionalized resin, selected from resins such as RinkAmide, Ramage, Sieber, H-AA-O-Wang, or H-AAZ-O-CTC resin. The coupling reaction was allowed to proceed for a period of 30 minutes to 2 hours at ambient temperature.

[0334] Following completion of the coupling reaction, the reaction mixture was filtered off, and the resin was washed several times with the corresponding solvent to remove excess reagents and by-products. The Fmoc protecting group was then removed by treatment with a solution of a secondary amine, such as piperidine, 4-methylpiperidine, piperazine, morpholine, or diethylamine, in the corresponding solvent at a concentration of 10 to 60%, or alternatively with a mixture comprising DBU and a secondary amine at concentrations of 2 to 5% each, for a period of 5 to 30minutes. After deprotection, the resin was washed again with the corresponding solvent to remove residual deprotection agents.

[0335] The process of coupling, washing, deprotection, and washing was repeated iteratively until the full sequence of the desired target peptide was assembled on the resin.

[0336] EXAMPLE 7

[0337] General LPPS Procedure

[0338] Salts of 3-(((tert-butylimino)methylene)amino)-N, N-dimethylpropan-l -amine (TBDC) were used for peptide bond formation in a non-polar solvent system. TBDC salt (1.6 to 2.0 equivalents) was mixed with Fmoc-AAY-OH (1.2 to 2.0 equivalents) and a coupling additive (1.6 to 2.0 equivalents) selected from OxymaPure, 1 -hydroxybenzotriazole (HOBt), 1-hydroxy-7-azabenzotriazole (HOAt), l-hydroxy-6-oxo-lH-benzotriazole (HOOBt), or l-hydroxy-7-oxo-lH-pyrrolo[2,3-b]pyridine (HOPO), dissolved in a corresponding non-polar solvent such as tetrahydrofuran (THF) or anisole. The mixture was prepared either in the presence or absence of a tertiary amine, such as diisopropylethylamine (DIEA) or triethylamine (TEA), added in amounts of 1.6 to 2.0 equivalents. The resulting reaction mixture was left to pre-activate for 1 to 10 minutes.

[0339] Following activation, the mixture was added to an amino-functionalized linker system attached to a polycarbonate tag (TAG), such as RinkAmide-TAG, Ramage-TAG, Sieber-TAG, AA-Wang-TAG, or AA-CTC-TAG. The reaction was allowed to proceed for 30 to 60 minutes or until a ninhydrin test indicated complete conversion of the amino component. After coupling, piperidine (10 to 25 equivalents) was added directly to the reaction mixture and left to react for 10 to 30 minutes to remove the Fmoc protecting group.

[0340] Following deprotection, the reaction mixture was concentrated, and 6 to 10 volumes of a cold polar solvent, selected from methanol (MeOH), isopropanol (IPA), or acetonitrile (ACN), were added to induce precipitation or allow isolation of the peptide-linker-TAG by centrifugation. The solid was washed twice with additional cold polar solvent to remove residual reagents and byproducts. This cycle was repeated iteratively until the full target peptide sequence was assembled.

[0341] In an alternative approach, using anisole as the solvent, after completion of the peptide bond formation, piperazine (10 to 25 equivalents) was used for deprotection instead of piperidine. The anisole solution was sequentially washed with aqueous hydrochloric acid solution (three times), aqueous sodium carbonate solution (three times), and brine solution (three times), followed by drying over magnesium sulfate (MgSO₄). The washed and dried peptide-linker-TAG was then ready for the next coupling cycle, and the procedure was repeated until the desired peptide sequence was fully elongated.EXAMPLE 8

[0342] Acid effect on solubility

[0343] Comparative experiments were conducted to study the effect of the acid (salt) which is used in conjunction with the TBDC.

[0344] Scheme 2 and Table 4 below present the reaction used to demonstrate and compare the effect of the acid on solubility of the coupling reagent, and the results are presented in Table 5 below.

[0345] Scheme 2

[0346] CDI (2 eq)

[0347]

[0348] a- a: Trp - CH2(2-indole) a: Trp - CH2(2-indole)

[0349] b: Ser = CH2OH b: Ser = CH2OH

[0350] c: Thr = CH2CH(OH)CH3c: Thr = CH2CH(OH)CH3

[0351] d: Tyr=CH2(4-OH-Ph) d: Tyr=CH2(4-OH-Ph)

[0352] e: Arg = CH2CH2CH2c(NH)2NHe: Arg = CH2CH2CH2c(NH)2NH

[0353] Table 4

[0354]

[0355] Table 5

[0356]

[0357] Wherein TsOH: p-Toluenesulfonic acid; MsOH: Methanesulfonic acid; Oxyma Pure®: Ethyl cyano(hydroxyimino)acetate; DIPEA: diisopropylethylamine; DMF: dimethyl formamide; DCM: dichloromethane; DEC: diethyl carbonate; NOP: A-octyl pyrrolidone; NBP: A-butyl pyrrolidone, DMC: dimethyl carbonate; EtOAc: ethyl acetate; DMSO: dimethylsulphoxide; PrOAc: propyl acetate; 'PrOAc: isopropyl acetate;tBuOAc: tertbutyl acetate; CPME: cyclopentyl methyl ether; 2-MeTHF: 2-methyl tetrahydrofuran; GVL: gamma Valero lactone; DOS: 1,3-diossolane; and TEP: triethyl phosphate.

[0358] Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims.All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting.

Claims

WHAT IS CLAIMED IS:

1. A composition of matter comprising a compound having the formula:3-(((?er?-butylimino)methylene)amino)-^’^ -dimethylpropan- 1 -amineand an acid,wherein a ratio of said compound to said acid ranges 1.1:0.9 - 0.9- 1.1.

2. The composition of matter of claim 1, wherein said acid is selected for the group comprising p-toluenesulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, 2-naphthalenesulfonic acid, 1,2-ethanedisulfonic acid, camphorsulfonic acid, nonafluorobutanesulfonic acid, dioctyl sulfosuccinic acid, chloro sulfonic acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, and trifluoroacetic acid.

3. The composition of matter of claim 1 or claim 2, isolated in a solid form.

4. The composition of matter of claim 1 or claim 2, isolated in a liquid solution form.

5. The composition of matter of any preceding claim, existing substantially in an open-chain form.

6. The composition of matter of any preceding claim, wherein said ratio is 1:1.

7. A method of forming an amide bond, comprising:providing the composition of matter of any one of claims 1-6, and dissolving said composition of matter in a liquid medium to form a reaction mixture; andi. adding a carboxylic acid to said reaction mixture, andii. adding an amine to said reaction mixture.

8. The method of claim 7, wherein said liquid medium in an aqueous solution and / or a water miscible solvent.

9. The method of claim 8, wherein said water miscible solvent is selected from the group comprising acetone, dimethyl sulfoxide (DMSO), ethanol, methanol, isopropanol (2-propanol), propylene glycol (1,2-propanediol), ethylene glycol, glycerol, acetonitrile, 1,4-dioxane, tetrahydrofuran (THF), N, N-dimethylformamide (DMF), N-methyl-2-pyrrolidone (NMP), pyridine, triethylamine (TEA), diisopropylethylamine (DIPEA) formamide, dimethylacetamide (DMAc), t-butyl alcohol, acetaldehyde, 2-methoxyethanol, 2-ethoxyethanol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol and any mixture thereof.

10. The method of claim 9, wherein said water miscible solvent is selected from the group comprising ethanol, methanol, isopropanol, propylene glycol, ethylene glycol, glycerol, acetone, acetonitrile and any mixture thereof.

11. The method of any one of claims 7-10, effected iteratively in a peptide synthesis process using at least two amino acid building blocks, wherein at least one of said amino acid building blocks is said carboxylic acid.

12. The method of claim 11, wherein said peptide synthesis is conducted in solid phase.

13. The method of claim 7, wherein said medium is a solvent that is substantially immiscible in water.

14. The method of claim 13, wherein said solvent is a green solvent, as defined in a recognized solvent selection guide selected from the group consisting of the CHEM21 guide, the Pfizer guide, and the GSK guide.

15. The method of claim 14, wherein said solvent include ethyl acetate (EtOAc), methyl ethyl ketone (MEK), isopropyl acetate (IPAc), cyclopentyl methyl ether (CPME), 2-methyltetrahydrofuran (2-MeTHF), dimethyl carbonate (DMC), propylene carbonate (PC), y-valerolactone (GVL), dimethyl isosorbide (DMI), ethylene carbonate (EC), and any combination thereof.

16. The method of any one of claims 13-15, effected iteratively in a peptide synthesis process using at least two amino acid building blocks, wherein at least one of said amino acid building blocks is said carboxylic acid.

17. The method of claim 16, wherein said peptide synthesis is conducted in solution phase.

18. The method of any one of claims 13-17, further comprising, subsequent to said adding, washing said reaction mixture with an aqueous solution.

19. The method of any one of claims 16-18, wherein at one of said at least two amino acid building blocks is selected from the group comprising histidine building block, an arginine building block, a threonine building block, a tryptophan building block, a serine building block, and a tyrosine building block, and wherein a side-chain thereof is not protected.

20. The method of claim 16, wherein said peptide synthesis is conducted in solid phase.

21. The method of any one of claims 16 to 20, wherein at one of said at least two amino acid building blocks is selected from the group comprising histidine building block, an arginine building block, a threonine building block, a tryptophan building block, a serine building block, and a tyrosine building block, and wherein a side-chain thereof is not protected.

22. The method of any one of claims 7 to 12, wherein said amide bond formation occurs with a conversion of at least 95% and with an L: D enantiomeric ratio greater than 95:5.

23. The composition of matter of any one of claims 1-6, further comprising:a polar or non-polar solvent;at least one reactant that comprises at least one amine and / or at least one carboxylic acid; and / orat least one product that comprises at least one amide or at least one peptide.

24. The composition of matter of claim 23, wherein said solvent is selected from the group consisting of water, ethyl acetate, methyl ethyl ketone, isopropyl acetate, cyclopentyl methylether, 2-methyltetrahydrofuran, dimethyl carbonate, propylene carbonate, y-valerolactone, dimethyl isosorbide, ethylene carbonate, tetrahydrofuran (THF), anisole, and mixtures thereof.

25. The composition of matter of claim 23 or claim 24, wherein said solvent comprises water or a mixture of water with a water-miscible solvent selected from acetone, dimethyl sulfoxide (DMSO), ethanol, methanol, isopropanol, propylene glycol, ethylene glycol, glycerol, acetonitrile, 1,4-dioxane, tetrahydrofuran (THF), N, N-dimethylformamide (DMF), N-methyl-2-pyrrolidone (NMP), pyridine, triethylamine (TEA), diisopropylethylamine (DIPEA), formamide, dimethylacetamide (DM Ac), t-butyl alcohol, acetaldehyde, 2-methoxy ethanol, 2-ethoxy ethanol, 1,3-propanediol, 1,2-butanediol, 1,3 -butanediol, and 1,4-butanediol.

26. The composition of matter of any one of claims 23 to 25, wherein said amine and said carboxylic acid are amino acid building blocks.

27. The composition of matter of claim 26, wherein at least one of said amino acid building blocks is unprotected on its side chain.

28. The composition of matter of claim 27, wherein said unprotected amino acid building block is selected from the group consisting of arginine, histidine, threonine, tryptophan, serine, and tyrosine.

29. The composition of matter of any one of claims 23 to 28, wherein said compound and said acid at said ratio constitute a coupling reagent, said coupling reagent is present in the composition of matter an amount of 1.1 to 7.5 equivalents relative to the total amount of said at least one reactant.

30. The composition of matter of any one of claims 23 to 29, further comprising a tertiary base selected from the group consisting of triethylamine (TEA) and diisopropylethylamine (DIPEA).

31. The composition of matter of any one of claims 23 to 30, further comprising a coupling additive.

32. The composition of matter of any one of claims 23 to 31, in the form of a single homogeneous phase.